| Catalyst | Drug/Treatment | Stage | Probability of Approval | Description | Drug Type | Therapeutic Area | Source |
|---|---|---|---|---|---|---|---|
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology | ||
PDUFA 2026 | Phase 3 | -% | FDA review of the new drug application for the treatment of example condition. Read More | Small Molecule | Oncology |
Recent Updates
Recently added Catalysts
West Pharmaceutical Services, Inc.$357.66
+3.98 (+1.13%)
Market Cap
22.35 B
EPS
7.52
P/E Ratio
42.3 $
Value Trade
199.99 M
SEC Financials
Q1 2026Dilution Risk
Revenue
844.90 M
R&D Expenses
15.80 M
Operating CF
89.90 M
Total Assets
4.11 B
Total Liabilities
1.12 B
Equity
2.99 B
D/E Ratio
12,345
6.62 %
Week
14.72 %
1 Month
31.17 %
3 Month
21.79 %
6 Month
-5.27 %
5 Year
28,422.37 %
All Time
Cash Data
Cash Position
521.40 M
Monthly Burn
-
Runway
12,345 mo
Burn Trend
StableSEC Filing
Apr 23, 2026
Overview
Volume
545.48 K
52 Week Range
206.10 - 330.88
% held by Insiders
0.64 %
% held by Institutions
104.2 %
Enterprise Value
22.15 B
Total Shares
72.04 M
Short %
3.2 %
Float Shares
71.61 M
Company Description
locked
Upcoming Catalyst
Catalyst Timeline
Dated clinical, regulatory & corporate events for West Pharmaceutical Services, Inc.
1Total events
0Upcoming
1Tier-1 (high impact)
2026 – 2026Coverage
Event history 1
Jul 1, 2026
▲Partnership / LicenseCorporate
Completed sale and transfer of manufacturing and supply rights for SmartDose 3.5mL On-Body Delivery System
Drug Pipeline Intelligence
Clinical Trial Results
| Drug Name | Indications | Phase | Date | Trial Results Summary | Title | Source |
|---|---|---|---|---|---|---|
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement | |
Example Drug | Example indication for clinical evaluation | Phase 3 | 2025-12-01 | The study met its primary endpoint demonstrating statistically significant improvement. Read More | Phase 3 Study Results Announcement |
Inside Trades
YEARLY INSIDER TRANSACTIONS
Sector Avg.
INSIDERS
SOLDINSIDERS
BOUGHT
SOLDINSIDERS
BOUGHT
POSITIVE SENTIMENT Based on 22 Insiders Transactions
Hedge Funds
Shares Held
HEDGE FUNDS
SOLDHEDGE FUNDS
BOUGHT
SOLDHEDGE FUNDS
BOUGHT
POSITIVE SENTIMENT Based on 27 hedge funds in the last quarter
18 buying (3 new)·9 selling (1 exited)·2 unchanged
Hedge Funds invested in WST
| HedgeFund Name ( 3 ) | % of Portfolio | Current MV - | Shares Owned - | Activity Avg Price $0 |
|---|---|---|---|---|
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K | |
Example Capital Management | 2.5 % | 15.00 M | 250.00 K |
WST Institutional Ownership Trends
Current Insider %
5.20%
—+0.00%
Current Institutional %
62.40%
—+0.00%
Total Ownership
67.60%
Insider + Institutional
Data Points
1
1 Ticker(s)
Option Chain Statistics
| Expiration | Volume | Open Interest | Implied Volatility Calls | Implied Volatility Puts | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Calls | Puts | Put-Call Ratio | Calls | Puts | Put-Call Ratio | IV | OiWaIv | VWaIv | IV | OiWaIv | VWaIv | |
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
| 2026-07-17 | 0 | 0.00 | 0 | 0 | - | - | - | - | - | - | ||
Option Chain
| Calls | Strike | Puts | ||||
|---|---|---|---|---|---|---|
| Last Price | Volume | Open Interest | Last Price | Volume | Open Interest | |
| No data available | ||||||
Open interest
Today's Open Interest
1.00 M
Put-Call Ratio
1.1
Put Open Interest
480.00 K
Call Open Interest
520.00 K
Open Interest Avg (30-day)
900,000
Today vs Open Interest Avg (30-day)
11.11%
Option Volume
Today's Volume
750.00 K
Put-Call Ratio
0.95
Put Volume
360.00 K
Call Volume
390.00 K
Volume Avg (30-day)
800,000
Today vs Volume Avg (30-day)
-6.25%
Company News
WST▲ +1.1%today
West to Host Second-Quarter 2026 Conference Call
West Pharmaceutical Services, Inc. will release its second-quarter 2026 financial results on July 23, 2026, before the market opens. Following the release, a conference call will be held at 8:00 a.m. Eastern Time to discuss the results and future business expectations. Participants must register in advance to ask questions during the call.
Read more →WSTWest Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System
West Pharmaceutical Services, Inc. has successfully completed the sale and transfer of manufacturing and supply rights for its SmartDose® 3.5mL On-Body Delivery System. The transaction closed on July 1, 2026, as planned. West will maintain its focus on developing other SmartDose products, including the 10mL version, ensuring ongoing innovation in injectable drug delivery.
Read more →WSTWest Appoints Michel Lagarde to be President and Chief Executive Officer
West Pharmaceutical Services has appointed Michel Lagarde as the new President and CEO, effective August 31, 2026. Lagarde succeeds Eric M. Green, who will retire from his roles. The transition also includes Robert F. Friel becoming Board Chair. Lagarde aims to enhance the company's reputation and focus on delivering innovative therapies in the evolving life sciences industry.
Read more →WSTWest to Participate in Upcoming Investor Conferences
West Pharmaceutical Services, Inc. announced its participation in upcoming investor conferences. The company, known for its innovative solutions in injectable drug administration, will provide live webcasts for these events, which will also be available for replay. West continues to support drug developers with high-quality solutions and reported significant net sales in the previous fiscal year.
Read more →WST▲ +12.9%on this newsshared move
West Reports First-Quarter 2026 Results
West Pharmaceutical Services, Inc. reported a strong performance for the first quarter of 2026, with net sales of $844.9 million, a 21% increase year-over-year. The company also raised its full-year revenue guidance to between $3.295 billion and $3.350 billion and adjusted diluted EPS guidance to a range of $8.40 to $8.75. Notable growth was observed in the High-Value Products Components segment, driven by significant demand for GLP-1 and non-GLP-1 products. The outlook for the second quarter appears optimistic, with anticipated net sales between $830 million and $850 million.
Read more →WSTWest to Host First-Quarter 2026 Conference Call
West Pharmaceutical Services, Inc. will announce its first-quarter 2026 financial results on April 23, 2026. A conference call is scheduled for 8:00 a.m. Eastern Time to discuss these results and future business expectations. Participants can register in advance to ask questions during the call, which will also be available for replay on the company's website.
Read more →WSTWest Expands Dublin Facility to Support High-Volume Injectable Therapies, Including Diabetes and Obesity
West Pharmaceutical Services has opened a new 165,000 square foot facility in Dublin to enhance its contract services for high-volume injectable therapies, particularly for diabetes and obesity. This expansion aims to meet the increasing global demand for complex drug delivery systems. The facility will support advanced automation and expanded drug-handling capabilities, reinforcing West's commitment to providing reliable drug delivery solutions.
Read more →WSTEric M. Green Informs Board of Plans to Retire as President, CEO and Chair of the Board of West Pharmaceutical Services, Inc. West Pharmaceutical Services, Inc. (NYSE: WST) announced today that Eric M. Green has informed the Board of Directors that he plans to retire from...
Eric M. Green, President, CEO, and Chair of West Pharmaceutical Services, Inc. (WST), plans to retire once his successor is appointed, expected in the second half of 2026. His tenure of over eleven years saw significant revenue growth and a total shareholder return of roughly 350%. The Board is currently engaging an executive recruiting firm to facilitate the transition. Despite the leadership change, the company reaffirms its guidance and remains optimistic about its long-term growth and innovation capabilities.
Read more →WSTWest Announces Quarterly Dividend and Share Repurchase Program - February 17, 2026
West Pharmaceutical Services, Inc. announced a quarterly dividend of $0.22 per share, payable on May 6, 2026. Additionally, the company has authorized a new share repurchase program for up to $1 billion of its common stock. The timing and number of shares repurchased will depend on market conditions and other factors.
Read more →WSTWest Announces Quarterly Dividend and Share Repurchase Program On February 16, 2026, the Board of Directors of West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for...
West Pharmaceutical Services, Inc. announced a quarterly dividend of $0.22 per share, payable on May 6, 2026. Additionally, the Board of Directors authorized a new share repurchase program for up to $1 billion. The timing and number of shares repurchased will depend on various market factors. The previous repurchase program was fully utilized before its expiration.
Read more →WSTWest Reports Fourth-Quarter and Full-Year 2025 Results
West Pharmaceutical Services, Inc. reported strong financial results for Q4 and full year 2025, driven by significant growth in its High-Value Product Components segment. The company anticipates continued positive momentum into 2026, with a focus on operational excellence. However, challenges remain in the healthcare diagnostic devices market.
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2025 Conference Call
West Pharmaceutical Services, Inc. will release its fourth-quarter and full-year 2025 financial results on February 12, 2026. A conference call will follow at 8:00 a.m. Eastern Time to discuss these results and future business expectations. Participants can register in advance to ask questions during the call.
Read more →WSTWest Synchrony™ S1 Prefillable Syringe System Commercially Available at Pharmapack
West Pharmaceutical Services, Inc. announced the commercial availability of its West Synchrony S1 prefillable syringe system at Pharmapack 2026 in Paris. This system offers a variety of options for biologics and vaccines, showcasing West's commitment to innovation in drug delivery. The launch comes amid increasing demand for combination products and evolving healthcare delivery models.
Read more →WSTWest Signs Agreement to Sell the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System to AbbVie West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the...
West Pharmaceutical Services, Inc. has signed an agreement to sell its manufacturing and supply rights for the SmartDose® 3.5mL On-Body Delivery System to AbbVie for $112.5 million. The deal is subject to closing conditions and is anticipated to close in mid-2026. While revenues from the 3.5mL system are forecasted to be about 4% of West's revenues in fiscal year 2025, the company will continue to develop other SmartDose products.
Read more →WSTWest to Participate in Upcoming Investor Conference
West Pharmaceutical Services, Inc. will present at the J.P. Morgan Healthcare Conference on January 14, 2026. The event will be accessible via a live webcast, with a replay available for 90 days. West is recognized for its innovative solutions in injectable drug administration and reported $2.89 billion in net sales for fiscal year 2024.
Read more →WSTWest Declares Quarterly Dividend
West Pharmaceutical Services, Inc. announced a quarterly dividend of $0.22 per share, payable on February 4, 2026, to shareholders of record on January 28, 2026. This decision highlights the company's solid financial performance and commitment to returning value to shareholders. West is recognized for its innovative solutions in injectable drug administration.
Read more →WSTWest Synchrony™ Prefillable Syringe System Launches at CPHI: Redefining a system-level solution for drug delivery
West Pharmaceutical Services, Inc. has launched its West Synchrony Prefillable Syringe System at CPHI Worldwide in Frankfurt, Germany. This system aims to provide a comprehensive solution for biologics and vaccines, streamlining the syringe selection process for pharmaceutical companies. The product is set to be commercially available in January 2026, promising to enhance efficiency in drug delivery.
Read more →WSTWest to Participate in Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. has announced its participation in upcoming investor conferences, highlighting its commitment to investor engagement. The company, a leader in injectable drug administration solutions, will provide live webcasts for each event. West has a strong manufacturing presence globally, supporting drug developers by delivering essential components for medical devices. The positive financial performance in fiscal 2024, with net sales of $2.89 billion, underscores the company's market position.
Read more →WST▲ +10.9%on this newsshared move
West Reports Third-Quarter 2025 Results
West Pharmaceutical Services, Inc. reported strong financial results for Q3 2025, with revenues and profits exceeding guidance. The company achieved double-digit growth in its HVP Components business, bolstered by demand for GLP-1 products. Management has raised its full-year revenue and EPS guidance due to ongoing positive momentum across its segments.
Read more →WSTWest to Host Third-Quarter 2025 Conference Call
West Pharmaceutical Services, Inc. announced it will release its third-quarter financial results on October 23, 2025, followed by a conference call at 8:00 a.m. ET. Participants can register in advance to ask questions during the call. A slide presentation will be available on the company's website, and a replay of the webcast will be accessible for 90 days post-event.
Read more →WSTWest to Participate in Upcoming Investor Conferences in September 2025
West Pharmaceutical Services, Inc. announced its participation in several investor conferences scheduled for September 2025. The company, known for its innovative injectable solutions, aims to strengthen its relationship with investors. With a strong fiscal performance, West continues to be a key player in the pharmaceutical industry.
Read more →WST▲ +22.8%on this news
West Announces Second-Quarter 2025 Results and Fourth-Quarter 2025 Dividend, Updates Full-Year 2025 Guidance
West Pharmaceutical Services, Inc. reported strong second-quarter 2025 results, exceeding expectations with a 10.7% increase in net sales compared to the previous year. The company attributed this growth to robust demand for High-Value Product components and favorable foreign exchange rates. As a result, West has raised its revenue and adjusted-diluted EPS guidance for the full year 2025.
Read more →WSTWest Welcomes Robert McMahon as Incoming Chief Financial Officer
West Pharmaceutical Services has appointed Robert McMahon as its new Chief Financial Officer, effective August 4, 2025. McMahon, who has a strong background in finance and executive roles within the healthcare sector, will succeed Bernard Birkett, who is retiring. The company expresses confidence in McMahon's ability to drive financial success and support long-term growth.
Read more →WSTWest to Host Second-Quarter 2025 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. announced that it will release its second-quarter financial results on July 24, 2025, before the market opens, followed by a conference call at 8:00 a.m. Eastern Time. Registration is required for participants wishing to ask questions during the call. The company's efforts in providing innovative injectable solutions have solidified its status as a key player in the pharmaceutical industry, supporting drug developers with high-quality components. This announcement highlights the company's ongoing commitment to transparency and investor communication.
Read more →WSTWest Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend
West Pharmaceutical Services, Inc. reported first-quarter 2025 financial results, revealing net sales of $698 million, a slight increase compared to the previous year. The company raised its guidance for both net sales and adjusted-diluted EPS for the full year, reflecting confidence in its financial performance. However, diluted EPS showed a decrease year-over-year, and specific product segments faced sales declines. A third-quarter dividend of $0.21 per share was also declared.
Read more →WSTWest Announces Leadership Changes West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced executive ...
West Pharmaceutical Services announced a leadership transition with Bernard J. Birkett set to retire as CFO, initiating a search for his successor. Shane Campbell has been appointed as the new Senior Vice President, Chief Proprietary Segment Officer, bringing significant experience from his previous role at Carlisle Companies. The changes are part of West's succession planning process, aimed at ensuring continued growth and support for the company's innovative strategies in injectable drug administration.
Read more →WSTWest Announces First-Quarter 2025 Results, Increases Adjusted-Diluted EPS Guidance and Declares Third-Quarter 2025 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2025 and declared a third-quarter 2025...
West Pharmaceutical Services, Inc. reported solid financial results for the first quarter of 2025, with revenues and adjusted-diluted EPS surpassing initial guidance. The company also declared a third-quarter dividend and highlighted positive trends, particularly in self-injection device sales. Despite these successes, some segments did experience declines, including a slight decrease in Contract-Manufactured Products and challenges in the Generics market unit. Overall, while West demonstrated strong cash flow and positive growth, certain areas will require ongoing monitoring.
Read more →WSTWest to Host First-Quarter 2025 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. (NYSE: WST) will announce its first-quarter financial results on April 24, 2025, followed by a conference call at 9:00 a.m. ET. The company encourages participants to register in advance to ask questions during the call. A replay of the conference call and associated webcast will be available for 90 days after the event. West continues to be a significant provider of injectable solutions and devices, contributing to patient care worldwide.
Read more →WSTWest Announces Second-Quarter Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
West Pharmaceutical Services, Inc. has declared a second-quarter dividend of $0.21 per share, payable on May 7, 2025, to shareholders recorded by April 30, 2025. The announcement reflects the company's strong performance and commitment to returning value to its shareholders. With over 10,000 employees worldwide and a significant manufacturing presence, West continues to support drug developers in safe and efficient medicine delivery.
Read more →WST▼ -38.2%on this news
West Announces Fourth-Quarter and Full-Year 2024 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2024 and introduced 2025...
West Pharmaceutical Services, Inc. has announced its financial results for Q4 and full-year 2024, reporting strong revenues and profits that exceeded expectations. The company noted a return to positive organic growth despite a decline in overall net sales for the year. Full-year 2024 net sales were reported at approximately $2.893 billion, reflecting a slight decline compared to the prior year. Looking ahead, West has set optimistic financial guidance for 2025, expecting continued growth driven by high-value products and a focus on operational excellence.
Read more →WST▼ -38.2%on this news
West Announces Fourth-Quarter and Full-Year 2024 Results
West Pharmaceutical Services, Inc. has announced its financial results for the fourth quarter and full year of 2024, showcasing a slight increase in quarterly sales but a decrease in adjusted earnings per share. The company expects continued growth in 2025, particularly in its Proprietary Products segment, with anticipated net sales between $2.875 billion and $2.905 billion. Despite some challenges, such as lower sales in certain product lines and currency exchange headwinds, management expresses optimism for future profitability and operational excellence.
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2024 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. (NYSE: WST) has announced plans to release its fourth-quarter and full-year financial results for 2024 on February 13, 2025. Following this announcement, a conference call will be held at 9:00 a.m. Eastern Time to discuss the results and future business expectations. Investors can access the live webcast on the company's Investor Relations website, and a slide presentation will be available on the day of the call. The company emphasizes its innovative and high-quality solutions in the injectable drug administration market.
Read more →WSTWest Announces First-Quarter Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
West Pharmaceutical Services, Inc. has announced a first-quarter dividend of $0.21 per share, which will be distributed on February 11, 2025, to shareholders of record as of February 7, 2025. This move underscores the company's strong financial performance, having generated $2.95 billion in net sales in fiscal year 2023. West continues to position itself as a leading provider of innovative solutions for injectable drug administration, supporting both established and emerging drug developers worldwide.
Read more →WSTWest Introduces Daikyo PLASCAP® RUV Closures in New Nested Format at Pharmapack West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
West Pharmaceutical Services, Inc. has announced the launch of its Daikyo PLASCAP® Ready-to-Use Validated closures in a new nested format at the Pharmapack event in Paris. This innovative offering is designed to meet the complex challenges of drug containment for advanced therapy molecules, particularly in the growing sector of gene and viral therapies. The new format is compatible with various vial sizes and aims to support the increasing regulatory requirements within the market. West continues to be a leader in pharmaceutical packaging, emphasizing its commitment to ensuring safe and effective drug delivery.
Read more →WSTWest Pharmaceutical Services to Present at the CJS 25th Annual New Ideas for the New Year Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that...
West Pharmaceutical Services, Inc. will be presenting at the CJS 25th Annual "New Ideas for the New Year" Virtual Investor Conference on January 14, 2025. Key executives, including Cindy Reiss-Clark, Chad Winters, and John Sweeney, are scheduled to speak at the event. The presentation aims to highlight the company's innovative injectable drug administration solutions and its success in the industry, which includes generating $2.95 billion in net sales in the last fiscal year.
Read more →WSTInvestor Contact Media Contact John Sweeney, CFA Michele Polinsky Vice President, Investor Relations Vice President, Global Communications +1 (484) 790-0373 +1 (610) 594-3054 John.Sweeney westpharma.com Michele.Polinsky
West Pharmaceutical Services, Inc. has elected Janet Haugen to its Board of Directors, expanding the board to 12 members. Haugen, the former CFO of Unisys Corporation, offers over 20 years of experience in business transformation and corporate development. Her addition is seen as a valuable asset due to her unique combination of finance and technology expertise, which aims to enhance West's impact on healthcare delivery.
Read more →WSTWest Elects New Director to the Board West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
West Pharmaceutical Services, Inc. has appointed Janet Haugen to its Board of Directors, expanding the board to 12 members. Haugen is a seasoned professional with over 16 years as Chief Financial Officer at Unisys Corporation and has experience in corporate development and IT. Her expertise is expected to bolster West's strategic initiatives in providing innovative solutions for injectable drug administration. The move emphasizes West's focus on leadership capable of enhancing healthcare delivery.
Read more →WST▲ +15.4%on this newsshared move
West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend
West Pharmaceutical Services, Inc. announced its financial results for the third quarter of 2024, showing a minor decline in net sales but increasing its fiscal year guidance for both net sales and adjusted-diluted EPS. The company declared a fourth-quarter 2024 dividend, which marks a 5% increase over previous payments and reinforces its consistent dividend growth. Despite a small decrease in sales in key segments, management remains confident in West's long-term potential and market strategies. This announcement is bolstered by favorable currency movements impacting projections positively.
Read more →WST▲ +15.4%on this newsshared move
West Announces Third-Quarter 2024 Results, Increases Fiscal Year 2024 Guidance and Declares Fourth-Quarter 2024 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2024 and declared a fourth-quarter 2024...
West Pharmaceutical Services, Inc. announced its third-quarter 2024 financial results, highlighting a slight decline in net sales within its Proprietary Products Segment. Despite these challenges, the company has raised its fiscal year 2024 guidance and declared a dividend for the fourth quarter, showing confidence in its ongoing market strategy. Positive growth was noted in the self-injection device sector, although operating cash flow and free cash flow experienced significant decreases compared to the previous year.
Read more →WSTWest to Present on Large Volume Delivery Systems, Administration and Transfer Devices, and Prefillable Syringe Component Expertise at the PDA Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...
West Pharmaceutical Services, Inc. will participate in the 2024 PDA Conference in Phoenix, AZ, highlighting its expertise in injectable drug administration. The company plans to present various insights regarding high-volume drug delivery systems and device platforms that reduce risks in the drug delivery process. With the rising complexity of biologic drugs, West emphasizes its commitment to adapting its packaging and device strategies for evolving market demands. The presentation and posters will address innovative solutions and industry challenges, further establishing West's leadership in the sector.
Read more →WSTWest to Host Third-Quarter 2024 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. (NYSE: WST) will release its third-quarter financial results on October 24, 2024, before the market opens. The announcement includes a conference call scheduled at 9:00 a.m. Eastern Time for discussing the results and future business expectations. A live webcast will be available on the company’s Investor Relations website, and a recording will remain accessible for 90 days after the event. West continues to serve as a key player in the injectable drug administration market, helping customers with safe and effective delivery solutions.
Read more →WSTWest Wins Heart of Pharma Award at 2024 CPHI Pharma Awards West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce...
West Pharmaceutical Services, Inc. (WST) has been awarded the Heart of Pharma Award at the 2024 CPHI Awards in Milan, Italy, in recognition of its partnership with Fox Chase Cancer Center. The award highlights West's commitment to philanthropic and ethical initiatives in healthcare. West has supported Fox Chase for over two decades, contributing to a new mobile screening unit aimed at improving cancer detection in underserved areas. The new unit is expected to offer a variety of cancer screenings and support cancer research efforts.
Read more →WSTWest to Attend and Showcase Industry Leadership in Packaging and Containment at CPHI Worldwide Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its...
West Pharmaceutical Services, Inc. (NYSE: WST) announced its participation in the CPHI Worldwide Conference in Milan, Italy, where it will showcase its expertise in packaging and containment solutions for injectable drug administration. The company will focus on the revisions to EU GMP Annex 1, emphasizing the importance of quality control in drug manufacturing. Additionally, West is a finalist for a prestigious CPHI Award, highlighting its commitment to philanthropic initiatives. The awards ceremony will take place on October 8th.
Read more →WSTWest to Participate in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. will present at the Bank of America Global Healthcare Conference on September 18, 2024, in London, UK. The presentation will be accessible through a live audio webcast on the company's website, promoting transparency. For fiscal year 2023, West reported $2.95 billion in net sales, demonstrating its significant role in the healthcare sector. With a global workforce and extensive product offerings, West continues to support drug developers effectively.
Read more →WST▼ -14.4%on this news
West Announces Second-Quarter 2024 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2024 and updated full-year 2024 financial ...
West Pharmaceutical Services, Inc. reported its financial results for the second-quarter of 2024, showing a decline in net sales primarily due to customer destocking. The proprietary products segment experienced a significant decrease, while contract-manufactured products grew by 4.9%. Despite the challenges faced in the first half of the year, management expresses confidence in forthcoming organic growth by the fourth quarter and foresees opportunities for increasing market value. Financial guidance for the full year remains optimistic, anticipating stronger revenue performance in the latter half.
Read more →WST▼ -14.4%on this news
West Announces Second-Quarter 2024 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA
West Pharmaceutical Services, Inc. announced its second-quarter 2024 results, reporting a decline in net sales and earnings per share compared to the previous year. Despite the decrease, management expressed optimism about potential revenue increases in the latter half of the year, citing strong confirmation from orders and customer discussions. The company updated its full-year financial guidance to reflect a lower expected sales range and adjusted earnings per share. Ongoing challenges from customer destocking have impacted results, particularly in key product segments.
Read more →WSTWest to Host Second-Quarter 2024 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. (NYSE: WST) has announced it will release its second-quarter financial results on July 25, 2024. Following the release, a conference call will be held at 9:00 a.m. Eastern Time to discuss the results and future business expectations. Participants can register in advance to ask questions, and a live audio-only webcast will be available. The company is a leader in injectable drug administration solutions, generating significant net sales and providing essential services to drug developers.
Read more →WSTWest Introduces Daikyo Crystal Zenith® (CZ) Ready-to-Use Nested Vials in Tub at the International Society for Cell and Gene Therapy West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that it...
West Pharmaceutical Services, Inc. has announced the launch of its Daikyo Crystal Zenith (CZ) Nested Vials at the International Society for Cell and Gene Therapy Annual Meeting in Vancouver. These vials conform to ISO 8362-1 standards and are optimized for cell and gene therapies, offering features like cryogenic temperature integrity and minimal chemical interaction. This new product enhances West's existing CZ platform and provides flexible filling solutions for sensitive molecules. The company is recognized as a leader in pharmaceutical packaging, serving various drug developers worldwide.
Read more →WSTWest Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA
West Pharmaceutical Services, Inc. reported its first-quarter 2024 financial results, noting a net sales decline of 3.0% to $695.4 million and a 16.2% drop in reported diluted EPS. Despite these losses, the company reaffirmed its full-year net sales guidance of $3.000 - $3.025 billion and raised its adjusted-diluted EPS guidance to $7.63 - $7.88. Additionally, a third-quarter dividend of $0.20 per share was announced, with management maintaining a positive outlook for organic sales growth in the latter half of the year.
Read more →WSTWest Announces First-Quarter 2024 Results and Declares Third-Quarter 2024 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2024 and updated full-year 2024 financial...
West Pharmaceutical Services, Inc. reported its first-quarter 2024 financial results, revealing a 3.0% decline in net sales and a 16.2% drop in reported-diluted EPS compared to the previous year. Despite these declines, the company reaffirmed its full-year sales guidance while raising its adjusted-diluted EPS outlook. Additionally, a third-quarter dividend of $0.20 per share was approved by the Board of Directors.
Read more →WSTWest to Host First-Quarter 2024 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. (NYSE: WST) has announced its upcoming first-quarter financial results for 2024, which will be released before the market opens on April 25, 2024. Following the release, management will host a conference call at 9:00 a.m. ET to discuss the results and future expectations. The company continues to support drug developers with innovative solutions, maintaining a strong presence in the injectable drug administration market, while also providing an audio webcast for broader access and engagement.
Read more →WSTWest Announces Second-Quarter 2024 Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
West Pharmaceutical Services, Inc. has announced a second-quarter 2024 dividend of $0.20 per share, to be paid on May 1, 2024. Shareholders of record as of April 24, 2024, will be eligible for this dividend. The company continues to demonstrate strong financial performance, generating $2.95 billion in net sales in its fiscal year 2023, and operates globally with 10,000 team members across 50 sites. West is recognized for its innovative solutions in injectable drug administration.
Read more →WST▼ -14.1%on this newsshared move
West Announces Fourth-Quarter and Full-Year 2023 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2023 and introduced...
West Pharmaceutical Services, Inc. reported its financial results for Q4 and full-year 2023, showing a 3.3% increase in net sales for the fourth quarter. The company also provided guidance for 2024, expecting net sales between $3.000 billion and $3.025 billion. Despite strong growth in certain segments, the company anticipates moderated organic sales growth due to inventory management challenges.
Read more →WST▼ -14.1%on this newsshared move
West Announces Fourth-Quarter and Full-Year 2023 Results - Conference Call Scheduled for 9 a.m. EST Today - Exton, PA
West Pharmaceutical Services, Inc. announced its financial results for Q4 and FY 2023, reporting a net sales growth of 3.3% and a diluted EPS increase of 34.6% in Q4. They provided guidance for FY 2024, expecting net sales in the range of $3.000 billion to $3.025 billion, with organic sales growth of 2-3%. However, the company noted challenges, including lower organic sales growth and ongoing declines in COVID-19 related sales.
Read more →WSTWest Named to Newsweek's America's Greatest Workplaces 2024 for Diversity West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that it...
West Pharmaceutical Services, Inc. has been named one of America's Greatest Workplaces for Diversity 2024 by Newsweek, highlighting its commitment to diversity, equity, and inclusion. The recognition stems from comprehensive surveys conducted with over 220,000 individuals and analyses of more than 1.5 million company reviews. West emphasizes a collaborative environment, boasting that 44% of its senior leadership comprises women and people of color, and actively promotes community support through significant charitable contributions. This accolade reflects West's dedication to fostering a diverse workplace and enhancing the overall employee experience.
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2023 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. (NYSE: WST) is set to release its fourth-quarter and full-year 2023 financial results on February 15, 2024. Following the release, a conference call will take place at 9:00 a.m. Eastern Time, allowing stakeholders to engage with management. The company has a notable history of providing innovative solutions in the healthcare sector, with a strong commitment to improving drug delivery. Additionally, West will commemorate its century mark of innovation, emphasizing its significant contribution to the healthcare landscape.
Read more →WSTWest Announces First-Quarter 2024 Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
West Pharmaceutical Services, Inc. has announced a first-quarter 2024 dividend of $0.20 per share, which will be paid on February 7, 2024, to shareholders recorded by January 31, 2024. This decision reflects the company's strong financial position and commitment to returning value to its shareholders. The announcement also highlights West's ongoing role in the healthcare sector as a leader in injectable drug administration. Celebrating a century of innovation, West continues to supply vital components and services to the pharmaceutical industry.
Read more →WSTWest Receives FDA 510(k) Clearance for Vial2Bag Advanced® 13mm Admixture Device West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration systems, today announced...
West Pharmaceutical Services, Inc. has received FDA 510(k) clearance for its newly launched Vial2Bag Advanced® 13mm admixture device, which allows for a needle-free IV drug transfer. This device complements the existing 20mm version and is designed to improve drug preparation at the point-of-care. The launch coincides with West's centennial celebration in the injectable solutions market and was highlighted at the American Society of Health-System Pharmacists Midyear Clinical Meeting in Anaheim, CA.
Read more →WSTWest Pharmaceutical Services Appoints Nilesh Shah as Vice President and General Manager of Emerging Markets West Pharmaceutical Services, Inc. (West), a global leader in innovative solutions for injectable drug administration, today announced it has...
West Pharmaceutical Services has appointed Nilesh Shah as Vice President and General Manager of Emerging Markets. Based in Singapore, he will oversee operations in the Asia Pacific and South America regions. With 25 years of experience in the medical devices industry, Shah aims to enhance West's presence and leadership in these markets. His appointment comes as West celebrates its 100-year milestone in innovation.
Read more →WST▼ -8.6%on this news
West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend
West Pharmaceutical Services, Inc. announced its financial results for the third quarter of 2023, reporting net sales of $747.4 million, an 8.8% year-over-year increase. The company revised its full-year guidance, lowering it to $2.950 billion to $2.960 billion, while also increasing its adjusted-diluted EPS guidance to a new range of $7.95 to $8.00. Additionally, West declared a dividend of $0.20 per share for the fourth quarter, marking the 31st consecutive increase, amid a slowdown in restocking trends observed in its customer base.
Read more →WST▼ -8.6%on this news
West Announces Third-Quarter 2023 Results, Updates Full-Year 2023 Guidance and Declares Fourth-Quarter 2023 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2023, updated full-year 2023 financial...
West Pharmaceutical Services, Inc. reported strong financial results for the third quarter of 2023, highlighting organic net sales growth driven by high-value products and contract manufacturing. However, the company revised its full-year guidance due to a slowdown in restocking trends among significant pharmaceutical clients. Despite this, they project double-digit organic sales growth for the fourth quarter, indicating a positive outlook for specific product demand. The firm also declared a dividend for the fourth quarter, which reflects confidence in continued revenue generation.
Read more →WSTWest to Present on Development of Large Volume Delivery Systems, Self-injection Devices, and Prefillable Syringe Component Expertise at the PDA Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...
West Pharmaceutical Services, Inc. (NYSE: WST) will participate in the 2023 PDA Universe of Pre-Filled Syringes and Injection Devices Conference in Gothenburg, Sweden, to present its advancements in injectable drug delivery systems. The company will showcase various presentations and posters focused on industry challenges and advancements. This marks a notable occasion as West celebrates its 100th anniversary, emphasizing its continued leadership in the pharmaceutical sector. With a commitment to high-quality standards, West aims to address the evolving needs of drug developers and enhance patient care.
Read more →WSTWest to Host Third-Quarter 2023 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. (NYSE: WST) announced its plans to release third-quarter 2023 financial results on October 26, 2023. Following the results, the company will hold a conference call to discuss the outcomes and future business expectations. Participants can register to ask questions and access presentation materials on the company's Investor Relations website. The event reflects West's ongoing commitment to communication with investors and stakeholders.
Read more →WST▼ -6.5%on this news
West Announces Second-Quarter 2023 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2023 and updated full-year 2023 financial ...
West Pharmaceutical Services, Inc. reported its financial results for the second quarter of 2023, showing a decrease in proprietary product sales primarily due to reduced demand related to COVID-19. However, the company remains optimistic about the second half of the year, boosted by high-value product expansion projects. Contract-Manufactured Products segment demonstrated growth with a 15.3% increase in net sales. Despite challenges in specific market units, such as Biologics, overall demand trends for high-value products seem stable.
Read more →WST▼ -6.5%on this news
West Announces Second-Quarter 2023 Results
West Pharmaceutical Services, Inc. reported its financial results for the second quarter of 2023, revealing a decrease in net sales and earnings per share compared to the prior year. Despite these declines, the company raised its guidance for full-year net sales and adjusted-diluted EPS, reflecting optimism about high-value products and operational resilience. The decline in revenue was largely attributed to reduced demand for COVID-19 related products, although other segments demonstrated positive trends. West remains focused on capitalizing on its capacity expansion projects to drive future growth.
Read more →WSTWest to Host Second-Quarter 2023 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. will announce its second-quarter 2023 financial results before the markets open on July 27, 2023. Following the release, a conference call is scheduled for 9:00 a.m. Eastern Time to discuss the results and provide business expectations. Investors can access the webcast on the Company’s Investor Relations website, and a replay will be available for 30 days post-event. The announcement highlights West's commitment to delivering innovative solutions for drug administration as it marks a significant milestone of 100 years in the industry.
Read more →WSTWest's Ready Pack™ containment solution with Corning® Valor® RTU Vials utilizing Stevanato Group's EZ-fill® technology recognized for Best Technologies Award at INTERPHEX West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce...
West Pharmaceutical Services, Inc. (NYSE: WST) announced that its Ready Pack™ containment solution, which employs Corning® Valor® RTU Vials and Stevanato Group's EZ-fill® technology, has been awarded the Best Technologies Award at INTERPHEX. This award highlights the container's role in enhancing drug development and manufacturing scaling. The system aids in the transition for biopharmaceuticals from pilot assessments to commercial production. Celebrating 100 years in the industry, West maintains a significant presence in injectable drug solutions.
Read more →WSTWest Announces First-Quarter 2023 Results and
West Pharmaceutical Services, Inc. announced its financial results for the first quarter of 2023, revealing a slight decline in net sales and reported-diluted EPS. Despite these declines, the company reaffirmed its full-year organic sales growth outlook and updated its financial guidance, projecting improved net sales and adjusted-diluted EPS. The Board of Directors also declared a third-quarter 2023 dividend of $0.19 per share. The performance varied across market units, with Generics and Pharma exhibiting growth, while the Biologics segment faced challenges due to declining COVID-19 related sales.
Read more →WSTWest Announces First-Quarter 2023 Results and Declares Third-Quarter 2023 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2023 and updated full-year 2023 financial...
West Pharmaceutical Services, Inc. reported its financial results for the first quarter of 2023, highlighting a decline in net sales and income compared to the previous year. The company reaffirmed its positive outlook for full-year organic sales growth, driven by solid performance in its Generics and Pharma segments. However, it experienced a decline in the Proprietary Products segment, primarily due to reduced sales related to COVID-19. The company is also focused on capital expenditure for high-value product expansion and managing potential future demand.
Read more →WSTWest to Host First-Quarter 2023 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. (NYSE: WST) announced it will release its first-quarter 2023 financial results on April 27, 2023. Following this, a conference call is scheduled for 9:00 a.m. ET to discuss the results and future business expectations. Interested parties can access the call via a live audio-only webcast on the company’s Investor Relations website. West marks its 100-year anniversary in 2023, emphasizing its long history of innovation in healthcare.
Read more →WSTWest Announces Second-Quarter 2023 Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the...
West Pharmaceutical Services, Inc. has announced a second-quarter 2023 dividend of $0.19 per share, which will be paid on May 3, 2023, to shareholders of record as of April 26, 2023. This announcement highlights the company's ongoing commitment to rewarding shareholders as it celebrates a century of innovation in injectable drug administration solutions. With a strong financial background, West continues to serve as a critical partner to drug developers globally, emphasizing its significant role in enhancing patient care.
Read more →WST▲ +14.5%on this news
West Announces Fourth-Quarter and Full-Year 2022 Results
West Pharmaceutical Services, Inc. reported its financial results for the fourth quarter and full year of 2022, revealing a net sales decline of 3.0% in Q4, despite overall sales growth for the year. The company introduced 2023 guidance indicating expected growth in net sales and adjusted-diluted EPS. A new share repurchase program was approved, allowing for up to $1.0 billion in repurchases. Although the company anticipates a decline in COVID-19 related sales, demand continues to grow from biologic customers.
Read more →WST▲ +14.5%on this news
West Announces Fourth-Quarter and Full-Year 2022 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2022 and introduced...
West Pharmaceutical Services, Inc. announced its financial results for the fourth-quarter and full-year 2022, showing a solid finish to the year. Despite a decline in sales related to COVID-19 vaccines, the company reported positive overall demand growth, particularly from biologic customers. The full-year 2023 financial guidance was introduced, indicating management's focus on maintaining capacity amid ongoing inflationary pressures. The company also highlighted an increase in operating cash flow and a new share repurchase program.
Read more →WSTWest Expands Corning Collaboration and Launches First Product West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announces the...
West Pharmaceutical Services, Inc. has expanded its collaboration with Corning Incorporated by launching the West Ready Pack™ featuring Corning Valor® RTU Vials. This product combines advanced vial technology with West's quality components to enhance drug administration safety. The collaboration aims to develop integrated packaging solutions for drug developers, ensuring reliability and efficiency in drug delivery. Celebrating 100 years in the industry, West continues to innovate and support healthcare advancements.
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2022 Conference Call and Announces Participation in Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
West Pharmaceutical Services, Inc. will announce its fourth-quarter and full-year 2022 financial results on February 16, 2023. Following the announcement, a conference call will be held to discuss the results and future business expectations. Additionally, West will participate in key investor conferences, including the Barclays Global Healthcare Conference and the KeyBanc Life Sciences & MedTech Investor Forum. The company emphasizes its commitment to providing innovative injectable solutions and celebrates its 100th anniversary in the industry.
Read more →WSTWest Announces Three New Product Innovations at Pharmapack Europe West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...
West Pharmaceutical Services, Inc. has announced the debut of three new product innovations at Pharmapack Europe 2023, focusing on injectable drug administration solutions. These products include West Ready Pack™ with Corning Valor® RTU Vials, Daikyo Crystal Zenith® Syringe System, and FluroTec® Cartridge Plunger. The company aims to address the growing market needs for complex and sensitive molecules in drug delivery. This marks a significant milestone in West's commitment to enhancing patient adherence and meeting pharmaceutical challenges.
Read more →WSTWest Announces First-Quarter 2023 Dividend and Participation in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announces that the...
EXTON, Pa. , Dec. 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announces that the Company's Board of Directors has approved a first-quarter 2023 dividend of $0.19 per share. T
Read more →WSTWest to Attend and Showcase Industry Leadership in Packaging and Containment at CPhI Worldwide Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its...
EXTON, Pa. , Oct. 31, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced its participation at CPhI Worldwide in Frankfurt, Germany to showcase its leadership and experti
Read more →WST▼ -13%on this newsshared move
West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2022 and updated full-year 2022 financial...
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , Oct. 27, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the third-quarter 2022 and updated full-year 2022 financial guidance. Third-Quarter 2022 Summa
Read more →WST▼ -13%on this newsshared move
West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend
West Announces Third-Quarter 2022 Results, Updates Full-Year 2022 Guidance and Declares Fourth-Quarter 2022 Dividend - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, October 27, 2022 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial resu
Read more →WSTWest to Present on Development of Large Volume Delivery Systems, Self-injection Devices and Prefillable Syringe Component Expertise at the PDA Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...
Expert presentations and posters offer thought leadership in drug delivery innovation, patient adherence and pharmaceutical manufacturing EXTON, Pa. , Oct. 18, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injec
Read more →WSTWest to Host Third-Quarter 2022 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2022 financial results before the market opens on Thursday, O
Read more →WSTWest Announced as Company of the Year Finalist for Global Generics and Biosimilar Awards 2022 West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has...
EXTON, Pa. , Oct. 6, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it has been shortlisted for Company of the Year for 2022 Global Generics and Biosimilar Awards, w
Read more →WSTWest Makes Minority Investment in Dublin-Based Latch Medical, a Developer of Vaccine and Biologics Delivery Platforms West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has...
EXTON, Pa. , Aug. 11, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it has made a strategic investment in Latch Medical, a Dublin -based leader in next-generation v
Read more →WST▲ +6.1%on this news
West Announces Second-Quarter 2022 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2022 and updated full-year 2022 financial ...
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , July 28, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the second-quarter 2022 and updated full-year 2022 financial guidance. Second-Quarter 2022 Sum
Read more →WST▲ +6.1%on this news
West Announces Second-Quarter 2022 Results
West Announces Second-Quarter 2022 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, July 28, 2022 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the second-quarter 2022 and updated full-year 2022 financial guidance
Read more →WSTWest Elects New Director to the Board West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today the...
EXTON, Pa. , July 27, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today the Company's Board of Directors has elected Stephen Lockhart, M.D., Ph.D., as its newest member
Read more →WSTInvestor Contact Media Contact Quintin Lai Michele Polinsky Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3054 Quintin.Lai westpharma.com Michele.Polinsky westpharma.
Investor Contact Media Contact Quintin Lai Michele Polinsky Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3054 Quintin.Lai westpharma.com Michele.Polinsky westpharma.com West Elects New Director to the Board Exton, PA, July
Read more →WSTWest to Host Second-Quarter 2022 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , July 14, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2022 financial results before the market opens on Thursday,
Read more →WST▼ -6.1%on this newsshared move
West Pharmaceutical Services Releases 2021 Corporate Responsibility Report West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has recently released its ...
EXTON, Pa. , July 12, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, has recently released its 2021 Corporate Responsibility Report, reporting on the Company's environmental, social
Read more →WSTWest Introduces Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System at BIO International Convention West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , June 13, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will unveil its new Daikyo Crystal Zenith® 2.25mL Insert Needle Syringe System at BIO In
Read more →WSTWest Receives Exhibitor Award at INTERPHEX 2022 for Proprietary DeltaCube™ Modeling Platform West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it...
The DeltaCube™ Modeling Platform is an analytics platform aimed at container closure system (CCS) selection, optimization, and usage EXTON, Pa. , May 24, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable
Read more →WSTWest to Attend and Showcase Industry Leadership in Packaging and Containment at INTERPHEX 2022 West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its...
West to present on industry trends, enabling technologies, packaging components, and innovative DeltaCube™ Modeling Platform EXTON, Pa. , May 23, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug adm
Read more →WSTWest Announces Executive Leadership Appointments West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today the...
EXTON, Pa. , May 12, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today the appointment of West's Chief Financial Officer (CFO) Bernard J. Birkett to a newly combined po
Read more →WSTWest Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2022 and updated full-year 2022 financial...
- Conference Call Scheduled for 9 a.m. EDT Today - EXTON, Pa. , April 28, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the first-quarter 2022 and updated full-year 2022 financial guidance. First-Quarter 2022 Summ
Read more →WSTWest Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend
West Announces First-Quarter 2022 Results and Declares Third-Quarter 2022 Dividend - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, April 28, 2022 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the first-quarter 2022 and u
Read more →WSTWest to Host First-Quarter 2022 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , April 14, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2022 financial results before the market opens on Thursday,
Read more →WSTWest Receives Fred Simon Award and Edward Smith Packaging Science Award at 2022 PDA Annual Meeting West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its...
EXTON, Pa. , April 4, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that its Scientific Insights Lab team members, Liang Fang and Marissa Rase , received the 2021 F
Read more →WSTWest to Showcase Leadership and Advancements of Packaging Science at the 2022 PDA Annual Meeting West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced its...
West to moderate sessions, give keynote presentation, and share scientific posters, highlighting expertise in ensuring quality, sterility and stability of injectable drug products EXTON, Pa. , March 31, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a glob
Read more →WSTWest Names President and CEO Eric M. Green as Chair of the Board West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Eric M....
EXTON, Pa. , Feb. 28, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced Eric M. Green , President and CEO, will assume the additional responsibility of Chair of the Com
Read more →WSTWest Announces Second-Quarter 2022 Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the...
EXTON, Pa. , Feb. 23, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that the Company's Board of Directors has approved a second-quarter 2022 dividend of $0.18 per s
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2021 Results - Conference Call Scheduled for 9 a.m. EST Today - Exton, PA
West Announces Fourth-Quarter and Full-Year 2021 Results - Conference Call Scheduled for 9 a.m. EST Today - Exton, PA, February 17, 2022 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the fourth-quarter and full-year 2021 and introduce
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2021 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Feb. 3, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2021 financial results before the market opens
Read more →WSTWest Announces Landmark Collaboration with Corning in Pharmaceutical Injectable Drug Delivery West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced an...
EXTON, Pa. , Jan. 25, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced an exclusive supply and technology agreement with Corning Incorporated (NYSE: GLW ). The new col
Read more →WST▼ -5.8%on this news
West Announces First-Quarter 2022 Dividend and 2022 Share Repurchase Program West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the...
EXTON, Pa. , Jan. 5, 2022 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that the Company's Board of Directors have approved a first-quarter 2022 dividend of $0.18 per sh
Read more →WSTWest Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA
West Announces Third-Quarter 2021 Results and Declares Fourth-Quarter 2021 Dividend - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, October 28, 2021 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the third-quarter 2021 an
Read more →WSTWest's NovaGuard® SA Pro Safety System Recognized for Best Technologies Innovation at INTERPHEX West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce...
EXTON, Pa. , Oct. 25, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, is pleased to announce that its NovaGuard® SA Pro safety system – a single-use accessory for prefilled ISO stand
Read more →WSTWest Introduces DeltaCube™ Modeling Platform and NovaGuard® SA Pro Safety System for 0.5 mL Standard Glass Syringes at Interphex West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 19, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will unveil its DeltaCube™ Modeling Platform as well as the new NovaGuard® SA Pro Safety
Read more →WSTWest to Host Third-Quarter 2021 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 14, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2021 financial results before the market opens on Thursday, O
Read more →WSTInvestor Contact Media Contact Quintin Lai Michele Pelkowski Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3054 Quintin.Lai westpharma.com Michele.Pelkowski westpharm
Investor Contact Media Contact Quintin Lai Michele Pelkowski Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3054 Quintin.Lai westpharma.com Michele.Pelkowski westpharma.com West Elects New Director to the Board Exton, PA, Aug
Read more →WST▲ +5.4%on this news
West Announces Second-Quarter 2021 Results
West Announces Second-Quarter 2021 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, July 29, 2021 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the second-quarter 2021 and updated full-year 2021 financial guidance
Read more →WST▲ +5.4%on this news
West Announces Second-Quarter 2021 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2021 and updated full-year 2021 financial ...
EXTON, Pa. , July 29, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the second-quarter 2021 and updated full-year 2021 financial guidance. Second-Quarter 2021 Summary (comparisons to prior-year period) "Adjusted-d
Read more →WSTWest to Host Second-Quarter 2021 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , July 15, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2021 financial results before the market opens on Thursday,
Read more →WSTWest Announces Participation in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that...
EXTON, Pa. , May 25, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that management will present at the Jefferies Virtual Healthcare Conference at 2:30 PM ET on Tues
Read more →WSTWest Announces Third-Quarter Dividend and Participation in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
EXTON, Pa. , May 5, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2021 dividend of $0.17 per shar
Read more →WSTWest Announces First-Quarter 2021 Results
West Announces First-Quarter 2021 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, April 29, 2021 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the first-quarter 2021 and updated full-year 2021 financial guidance.
Read more →WSTWest Announces First-Quarter 2021 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2021 and updated full-year 2021 financial...
EXTON, Pa. , April 29, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the first-quarter 2021 and updated full-year 2021 financial guidance. First-Quarter 2021 Summary (comparisons to prior-year period) "Adjusted-di
Read more →WSTWest to Host First-Quarter 2021 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , April 15, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2021 financial results before the market opens on Thursday,
Read more →WSTWest Announces Participation in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences &...
EXTON, Pa. , March 17, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) announced that management will present virtually at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum at 10:00 AM ET on Wednesday , March 24, 2021. A live audio webcast o
Read more →WSTWest Announces Second-Quarter 2021 Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
EXTON, Pa. , Feb. 24, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a second-quarter 2021 dividend of $0 .17 per
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2020 Results
West Announces Fourth-Quarter and Full-Year 2020 Results - Conference Call Scheduled for 9 a.m. EST Today - Exton, PA, February 18, 2021 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the fourth-quarter, full-year 2020 and introduced f
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2020 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter, full-year 2020 and introduced full-year...
EXTON, Pa. , Feb. 18, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the fourth-quarter, full-year 2020 and introduced full-year 2021 financial guidance. Fourth-Quarter and Full-Year 2020 Summary (comparisons to pri
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2020 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Feb. 4, 2021 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2020 financial results before the market opens
Read more →WSTWest Announces First-Quarter 2021 Dividend, 2021 Share Repurchase Program and Participation in Upcoming Investor Conference
Investor Contact Media Contact Quintin Lai Michele Pelkowski Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3054 Quintin.Lai westpharma.com Michele.Pelkowski westpharma.com West Announces First-Quarter 2021 Dividend,
Read more →WSTWest Announces First-Quarter 2021 Dividend, 2021 Share Repurchase Program and Participation in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
EXTON, Pa. , Dec. 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2021 dividend of $0.17 per sha
Read more →WSTWest Appoints Kimberly Banks MacKay as Senior Vice President General Counsel and Corporate Secretary
Investor Contact Media Contact Quintin Lai Michele Pelkowski Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3054 Quintin.Lai westpharma.com Michele.Pelkowski westpharma.com West Appoints Kimberly Banks MacKay as Seni
Read more →WSTWest Appoints Kimberly Banks MacKay as Senior Vice President General Counsel and Corporate Secretary West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced it has...
EXTON, Pa. , Nov. 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced it has appointed Kimberly Banks MacKay to serve as Senior Vice President General Counsel and Corporate
Read more →WSTWest Announces Increase to Fourth-Quarter 2020 Dividend
Investor Contact Media Contact Quintin Lai Michele Pelkowski Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3054 Quintin.Lai westpharma.com Michele.Pelkowski westpharma.com West Announces Increase to Fourth-Quarter 2
Read more →WSTWest Announces Increase to Fourth-Quarter 2020 Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
EXTON, Pa. , Oct. 28, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a fourth-quarter 2020 dividend of $0.17 per s
Read more →WSTWest Announces Third-Quarter 2020 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial...
EXTON, Pa. , Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidance. Third-Quarter 2020 Summary (comparisons to prior-year period) "Adjusted-dil
Read more →WSTWest Announces Third-Quarter 2020 Results
West Announces Third-Quarter 2020 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, October 22, 2020 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the third-quarter 2020 and updated full-year 2020 financial guidanc
Read more →WSTWest Launches New Vial2Bag Advanced™ 20mm Admixture Device West Pharmaceutical Services, Inc. (NYSE: WST), West Pharmaceutical Services, Inc. (West) is pleased to announce FDA 510(k) clearance and launch of...
EXTON, Pa. , Oct. 22, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), West Pharmaceutical Services, Inc. (West) is pleased to announce FDA 510(k) clearance and launch of its Vial2Bag Advanced™ 20mm Admixture Device. The Vial2Bag Advanced™ 20mm Admixture Dev
Read more →WSTWest to Host Third-Quarter 2020 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 8, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2020 financial results before the market opens on Thursday, Oc
Read more →WSTWest Announces Second-Quarter 2020 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2020 and updated full-year 2020 financial ...
EXTON, Pa. , July 23, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the second-quarter 2020 and updated full-year 2020 financial guidance. Second-Quarter 2020 Summary (comparisons to prior-year period) "Adjusted-d
Read more →WSTWest Announces Second-Quarter 2020 Results
West Announces Second-Quarter 2020 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, July 23, 2020 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the second-quarter 2020 and updated full-year 2020 financial guidance
Read more →WSTWest Announces Third-Quarter 2020 Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
EXTON, Pa. , July 15, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2020 dividend of $0.16 per sh
Read more →WSTWest Announces Third Quarter 2020 Dividend
Investor Contact Media Contact Quintin Lai Michele Pelkowski Vice President, Investor Relations Sr. Director, Global Communications +1-610-594-3318 +1-610-594-3054 Quintin.Lai westpharma.com Michele.Pelkowski westpharma.com West Announces Third Quarter 2020 Dividend E
Read more →WSTWest to Host Second-Quarter 2020 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , July 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2020 financial results before the market opens on Thursday, J
Read more →WSTWest Pharmaceutical Services, Inc. to Join S&P 500 Index West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that it has...
EXTON, Pa. , May 21, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced that it has been named to the S&P ® 500, which will become effective after close of trading today. "We
Read more →WSTWest to Participate in Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it will...
EXTON, Pa. , May 7, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it will participate in the Bank of America Securities 2020 Healthcare Conference on Thursday, May
Read more →WSTWest Announces First-Quarter 2020 Results
West Announces First-Quarter 2020 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, April 23, 2020 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial guidance.
Read more →WSTWest Announces First-Quarter 2020 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial...
EXTON, Pa. , April 23, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the first-quarter 2020 and updated full-year 2020 financial guidance. First-Quarter 2020 Summary (comparisons to prior-year period) "Adjusted-di
Read more →WSTWest to Host Virtual Shareholders Meeting West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , April 20, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it is in the best interests of shareholders to hold a virtual shareholder meeting due to t
Read more →WSTWest to Host First-Quarter 2020 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , April 9, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2020 financial results before the market opens on Thursday, A
Read more →WSTWest Elects New Director to the Board
Investor Contact Media Contact Quintin Lai Emily Denney Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3035 Quintin.Lai westpharma.com Emily.Denney westpharma.com West Elects New Director to the Board Exton, PA, Feb
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2019 Results
West Announces Fourth-Quarter and Full-Year 2019 Results - Conference Call Scheduled for 9 a.m. EST Today - Exton, PA, February 13, 2020 - West Pharmaceutical Services, Inc. (NYSE WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduce
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2019 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2019 and introduced...
EXTON, Pa. , Feb. 13, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the fourth-quarter and full-year 2019 and introduced full-year 2020 financial guidance. Fourth-Quarter and Full-Year 2019 Summary (comparisons to
Read more →WSTWest Launches New Product Innovations at Pharmapack 2020 (Booth #B58) West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
EXTON, Pa. , Feb. 5, 2020 /PRNewswire/ -- (Booth #B58) West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce several new, innovative pharmaceutical containment and closur
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2019 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Jan. 30, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2019 financial results before the market opens
Read more →WSTWest Recognized as a Top Company for Corporate Responsibility West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, was recently named as a...
EXTON, Pa. , Jan. 28, 2020 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, was recently named as a Top Company for Corporate Responsibility practices by both Newsweek and Investor's Busin
Read more →WSTInvestor Contact: Media Contact: Quintin Lai Emily Denney Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3035 Quintin.Lai@westpharma.com Emily.Denney@westpharma.com We
Investor Contact: Media Contact: Quintin Lai Emily Denney Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3035 Quintin.Lai@westpharma.com Emily.Denney@westpharma.com West Announces First-Quarter Dividend, Share Repurchase Progr
Read more →WSTWest Announces First-Quarter Dividend, Share Repurchase Program and Participation in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
EXTON, Pa. , Dec. 13, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a first-quarter 2020 dividend of $0.16 per sh
Read more →WSTWest and SCHOTT Announce Partnership to combine the SCHOTT iQ® Platform with West's Ready Pack™ System (Booths #F62 & #F10 -Hall 11.1) West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug...
FRANKFURT, Germany , Nov. 6, 2019 /PRNewswire/ -- (Booths #F62 & #F10 -Hall 11.1 ) West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, and the international technology group SCHOTT, a leading primary packagi
Read more →WSTWest Launches Two New Elastomer Product Innovations at CPhI Worldwide (Booth #111F62)—West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
EXTON, Pa. , Nov. 5, 2019 /PRNewswire/ -- (Booth #111F62)— West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced two innovative product offerings in the elastomer space at the 2019 CPhI Worldwi
Read more →WSTWest Announces Third-Quarter 2019 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial...
EXTON, Pa. , Oct. 24, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidance. Third-Quarter 2019 Summary (comparisons to prior-year period) "Adjusted-dil
Read more →WSTWest Announces Third-Quarter 2019 Results
West Announces Third-Quarter 2019 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, October 24, 2019 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2019 and updated full-year 2019 financial guidan
Read more →WSTWest Introduces NovaPure® 3mL Cartridge Components and Features SmartDose® Gen. II 10mL Drug Delivery System at PDA Universe of Pre-filled Syringes and Injection Devices (Booths #F44 & #F51)—West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration,...
EXTON, Pa. , Oct. 22, 2019 /PRNewswire/ -- (Booths #F44 & #F51)— West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced two innovative product offerings at the 2019 PDA Universe of Pre-Filled Sy
Read more →WSTWest Increases Equity Stake in Daikyo Seiko, Ltd.
Investor Relations Contact: Media Contact: Quintin Lai Emily Denney Investor Relations, West Global Communications, West +1-610-594-3318 +1-610-594-3035 Quintin.Lai@westpharma.com Emily.Denney@westpharma.com West Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Compa
Read more →WSTWest Increases Equity Stake in Daikyo Seiko, Ltd. - Extending the Companies' Longstanding Partnership in Injectable Drug Delivery West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today...
EXTON, Pa. , Oct. 16, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it has increased its minority equity stake to 49 percent in Daikyo Seiko, Ltd.
Read more →WSTWest to Host Third-Quarter 2019 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 10, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2019 financial results before the market opens on Thursday, O
Read more →WSTWest Announces Participation in Upcoming September Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that...
EXTON, Pa. , Aug. 23, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that management will present an overview of the business at two investor conferences in Septembe
Read more →WSTWest Announces Second-Quarter 2019 Results and
West Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, July 25, 2019 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the secon
Read more →WSTWest Announces Second-Quarter 2019 Results and Announces an Increase to Fourth-Quarter 2019 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2019 and updated full-year 2019 financial ...
EXTON, Pa. , July 25, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the second-quarter 2019 and updated full-year 2019 financial guidance. Second-Quarter 2019 Summary (comparisons to prior-year period) "Adjusted-d
Read more →WSTWest to Host Second-Quarter 2019 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa., July 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2019 financial results before the market opens on Thursday, J
Read more →WSTWest NovaGuard® SA Pro Safety System Recognized for Excellence in Design and User Experience at the India Packaging Awards West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, is pleased to announce...
EXTON, Pa. , May 22, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, is pleased to announce that the NovaGuard® SA Pro safety system – a single-use accessory for prefilled ISO standa
Read more →WSTWest Announces Third-Quarter Dividend and Participation in Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that the...
EXTON, Pa. , May 8, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today that the Company's Board of Directors has approved a third-quarter 2019 dividend of $0.15 per shar
Read more →WSTWest Announces First-Quarter 2019 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial...
EXTON, Pa. , April 25, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance. First-Quarter 2019 Summary (comparisons to prior-year period) "Adjusted-di
Read more →WSTWest Announces First-Quarter 2019 Results
West Announces First-Quarter 2019 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, April 25, 2019 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2019 and updated full-year 2019 financial guidance
Read more →WSTWest Named as a Philadelphia Business Journal 2019 Faces of Philanthropy Honoree West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
EXTON, Pa. , April 12, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced the Company's recognition by the Philadelphia Business Journal as a 2019 Faces of Philanthropy
Read more →WSTWest to Host First-Quarter 2019 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , April 11, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2019 financial results before the market opens on Thursday,
Read more →WSTWest Expands Presence in Korea with New Sales Office West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has...
SEOUL, South Korea , April 3, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it has expanded its presence in the Asia Pacific region with a new sales office in Korea
Read more →WSTWest Opens New Digital Technology Center in Bengaluru, India West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today officially opened...
BENGALURU, India , March 8, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today officially opened the Company's new Digital Technology Center (DTC) in Bengaluru, India , a regional
Read more →WSTWest Announces Quarterly Dividend and Share Repurchase Program West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of...
EXTON, Pa. , Feb. 21, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors has approved a second-quarter 2019 dividend of $0.15 per share. The dividend will be paid on May 1, 2019 , to shareholders of record as
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2018 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial ...
EXTON, Pa. , Feb. 14, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the fourth-quarter and full-year 2018 and provided financial guidance for full-year 2019. Executive Summary "Adjusted-diluted EPS," "net sales at
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2018 Results
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 Quintin.Lai@westpharma.com West Announces Fourth-Quarter and Full-Year 2018 Results - Conference Call Scheduled for 9 a.m. EST Today - Exton, PA, February 14, 2019 - West Pharmaceutical Servic
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2018 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Jan. 31, 2019 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2018 financial results before the market opens
Read more →WSTWest Announces Quarterly Dividend and Participation in Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0....
EXTON, Pa. , Dec. 18, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors has approved a first-quarter 2019 dividend of $0.15 per share. The dividend will be paid on February 6, 2019 , to shareholders of recor
Read more →WSTWest Announces Participation in Upcoming November Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its...
EXTON, Pa. , Nov. 1, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor confe
Read more →WSTWest Announces Third-Quarter 2018 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third-quarter 2018 and reaffirmed net sales and...
EXTON, Pa. , Oct. 25, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the third-quarter 2018 and reaffirmed net sales and adjusted-diluted EPS guidance for full-year 2018. Executive Summary "Adjusted-diluted EPS," "
Read more →WSTWest Announces Third-Quarter 2018 Results
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 Quintin.Lai@westpharma.com West Announces Third-Quarter 2018 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, October 25, 2018 - West Pharmaceutical Services, Inc. (NYSE:
Read more →WSTWest to Host Third-Quarter 2018 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release third-quarter 2018 financial results before the market opens on Thursday, O
Read more →WSTWest Receives Excellence in Pharma: Corporate Social Responsibility Award at CPhI Worldwide West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 11, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it has received the 2018 Excellence in Pharma: Corporate Social Responsibility Award. The h
Read more →WSTWest Highlights Integrated Solutions Offering and Related Technical and Regulatory Expertise at Upcoming Industry Events West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 8, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will introduce a new Integrated Solutions Program to help to reduce risk, mitigate regula
Read more →WSTWest's President and CEO Eric M. Green Presented With CEO Connection 2018 Social Impact Award West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its...
EXTON, Pa. , Sept. 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that its President and CEO, Mr. Eric M. Green , has received the CEO Connection's 2018 Social I
Read more →WSTWest Announces Participation in Upcoming September Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its...
EXTON, Pa. , Aug. 23, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at three investor co
Read more →WSTWest Announces Second-Quarter 2018 Results
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 Quintin.Lai@westpharma.com West Announces Second-Quarter 2018 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, July 26, 2018 - West Pharmaceutical Services, Inc. (NYSE: WST)
Read more →WSTWest Announces Second-Quarter 2018 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2018 and reaffirmed financial guidance...
EXTON, Pa. , July 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the second-quarter 2018 and reaffirmed financial guidance for full-year 2018. Executive Summary "Adjusted-diluted EPS," "net sales at constant cu
Read more →WSTWest Celebrates Official Opening of New Global Manufacturing Facility in Waterford, Ireland and the launch of Westar® Select Component Offering West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
EXTON, Pa. , July 19, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced the official opening of its new Waterford, Ireland facility, a global center of excellence for W
Read more →WSTWest to Host Second-Quarter 2018 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , July 12, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release second-quarter 2018 financial results before the market opens on Thursday,
Read more →WSTWest Appoints Bernard Birkett to Chief Financial Officer West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has...
EXTON, Pa. , June 21, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Bernard J. Birkett to serve as Senior Vice President, Chief Financial Officer a
Read more →WSTWest's SelfDose™ Patient-Controlled Injector Wins Silver Medical Design Excellence Award (Booth #1933) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
EXTON, Pa. , June 13, 2018 /PRNewswire/ -- (Booth #1933) -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it has received the Silver Medical Design Excellence Award for "Drug-Deliv
Read more →WSTWest Announces Participation in Upcoming June Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its...
EXTON, Pa. , May 24, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor confe
Read more →WSTWest Announces Participation in Upcoming June Investor Conferences
Investor Contact: Media Contact: Quintin Lai Emily Denney Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3035 Quintin.Lai@westpharma.com Emily.Denney@westpharma.com West Announces Participation in Upcoming June Investor Confer
Read more →WSTWest Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0....
EXTON, Pa. , May 3, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors has approved a third-quarter 2018 dividend of $0.14 per share. The dividend will be paid on August 1, 2018 , to shareholders of record as
Read more →WSTWest Announces Third-Quarter Dividend, Increase to Fourth-Quarter Dividend and Participation in Upcoming Investor Conferences
Investor Contact: Media Contact: Quintin Lai Emily Denney Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3035 Quintin.Lai@westpharma.com Emily.Denney@westpharma.com West Announces Third-Quarter Dividend, Increase to Fourth-Qua
Read more →WSTWest Announces First-Quarter 2018 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2018 and reaffirmed financial guidance for ...
EXTON, Pa. , April 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the first-quarter 2018 and reaffirmed financial guidance for full-year 2018. Executive Summary "Adjusted-diluted EPS," "net sales at constant cu
Read more →WSTWest Announces First-Quarter 2018 Results
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 Quintin.Lai@westpharma.com West Announces First-Quarter 2018 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, April 26, 2018 - West Pharmaceutical Services, Inc. (NYSE: WST)
Read more →WSTWest to Host First-Quarter 2018 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , April 12, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2018 financial results before the market opens on Thursday,
Read more →WSTWest to Showcase DAIKYO PLASCAP® RUV One-Step Press-Fit Vial Closure Solution at PDA Annual Meeting (Booth #501) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
ORLANDO, Fla. , March 19, 2018 /PRNewswire/ -- (Booth #501) – West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it will showcase Daikyo's new innovation – the DAIKYO PLASCAP® RUV one-step p
Read more →WSTWest Chief Financial Officer William Federici Announces Plans to Retire
Investor Contact: Media Contact: Quintin Lai Emily Denney Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3035 Quintin.Lai@westpharma.com Emily.Denney@westpharma.com West Chief Financial Officer William Federici Announces Plans
Read more →WSTWest Chief Financial Officer William Federici Announces Plans to Retire West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced William...
EXTON, Pa. , March 2, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced William Federici , Senior Vice President, Chief Financial Officer and Treasurer, has communicate
Read more →WSTWest Appoints Silji Abraham Chief Digital and Transformation Officer West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Silji...
EXTON, Pa. , Feb. 26, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced Silji Abraham has been appointed Senior Vice President and Chief Digital and Transformation Offi
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2017 Results and
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 Quintin.Lai@westpharma.com West Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend - Conference Call Scheduled for 9 a.m. EST Today - Exton, PA, February 15, 2
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2017 Results and Announces Quarterly Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2017 and provided financial ...
EXTON, Pa. , Feb. 15, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the fourth-quarter and full-year 2017 and provided financial guidance for full-year 2018. Executive Summary "Adjusted-diluted EPS," "net sales at
Read more →WSTSelfDose™ Patient-Controlled Injector Named as Recipient of Pharmapack Exhibitor Innovation Award Booth #D20 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
PARIS , Feb. 7, 2018 /PRNewswire/ -- Booth #D20 -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that its SelfDose™ Patient-Controlled Injector was named a recipient of a 2018 Pharmapac
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2017 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Feb. 1, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2017 financial results before the market opens
Read more →WSTWest Announces Quarterly Dividend and Participation in Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2018 dividend of $0....
EXTON, Pa. , Dec. 22, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors has approved a first-quarter 2018 dividend of $0.14 per share. The dividend will be paid on February 1, 2018 , to shareholders of recor
Read more →WSTWest Announces Upcoming Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management ...
EXTON, Pa. , Nov. 15, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at the upcoming Jefferies 2017 London Heal
Read more →WSTWest Announces Upcoming Investor Conference
Investor Contact: Media Contact: Quintin Lai Emily Denney Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3035 Quintin.Lai@westpharma.com Emily.Denney@westpharma.com West Announces Upcoming Investor Conference EXTON, PA, Novem
Read more →WSTWest to Showcase New Extensions of the SmartDose® Drug Delivery Platform at the PDA Universe of Pre-filled Syringes and Injection Devices (Booth X67) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
VIENNA , Nov. 6, 2017 /PRNewswire/ -- (Booth X67) – West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it will, for the first time, showcase new extensions of its marketed SmartDose® drug de
Read more →WSTWest Announces Third-Quarter 2017 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2017, updated financial guidance for...
EXTON, Pa. , Oct. 26, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the third quarter of 2017, updated financial guidance for the full-year 2017, introduced sales growth outlook for full-year 2018 and reaffirmed lon
Read more →WSTWest Announces Third-Quarter 2017 Results
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 West Announces Third-Quarter 2017 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, October 26, 2017 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced its finan
Read more →WSTStudy Demonstrates Benefit of West's ID Adapter for Improving Intradermal Administration of Polio Vaccine West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today shared the results...
EXTON, Pa. , Oct. 10, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today shared the results of a study highlighting the benefits of West's ID Adapter for improving the intradermal
Read more →WSTWest Announces Fall Investor Conference Schedule West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced that management ...
EXTON, Pa. , Aug. 25, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced that management will be presenting a West business overview at three investor conferences in September
Read more →WSTWest Announces Second-Quarter 2017 Results
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 West Announces Second-Quarter 2017 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, July 27, 2017 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financi
Read more →WSTWest Announces Second-Quarter 2017 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second-quarter 2017 and updated financial guidance for...
EXTON, Pa. , July 27, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the second-quarter 2017 and updated financial guidance for the full-year 2017. Second-Quarter 2017 Highlights "Adjusted-diluted EPS" and "net sal
Read more →WSTWest Announces Increase to Quarterly Dividend West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
EXTON, Pa. , July 20, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced the Company's Board of Directors has approved a fourth-quarter 2017 dividend of $0.14 per share,
Read more →WSTWest Elects New Director to the Board West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Deborah Keller as its newest member....
EXTON, Pa. , June 1, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors elected Deborah Keller as its newest member. With the addition of Ms. Keller, West's Board of Directors increases in size to 11 director
Read more →WSTWest to Present on Biologics Trends at InnoPack Pharma Confex (Booth #B-3) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
EXTON, Pa. , May 30, 2017 /PRNewswire/ -- (Booth #B-3) -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will deliver a presentation on best practices for improving patient outco
Read more →WSTWest Announces Quarterly Dividend and Participation in Upcoming Investor Conferences
Investor Contact: Media Contact: Quintin Lai Emily Denney Vice President, Investor Relations Vice President, Global Communications +1-610-594-3318 +1-610-594-3035 Quintin.Lai@westpharma.com Emily.Denney@westpharma.com West Announces Quarterly Dividend and Participation in Upcomi
Read more →WSTWest Announces Quarterly Dividend and Participation in Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2017 dividend of $0....
EXTON, Pa. , May 15, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors has approved a third-quarter 2017 dividend of $0.13 per share. The dividend will be paid on August 2, 2017 to shareholders of record as
Read more →WSTWest Highlights Company Scientific and Regulatory Expertise at Notable Industry Meetings West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today that Fran ...
EXTON, Pa. , May 3, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today that Fran DeGrazio , Vice President Scientific Affairs and Technical Services, and Diane Paskiet ,
Read more →WSTWest Announces First-Quarter 2017 Results
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 West Announces First-Quarter 2017 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA, April 28, 2017 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financi
Read more →WSTWest Announces First-Quarter 2017 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first-quarter 2017 and updated financial guidance for...
EXTON, Pa. , April 27, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the first-quarter 2017 and updated financial guidance for the full-year 2017. First-Quarter 2017 Highlights "Adjusted diluted EPS" and "net sale
Read more →WSTWest to Host First-Quarter 2017 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , April 13, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release first-quarter 2017 financial results before the market opens on Thursday,
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed...
EXTON, Pa. , Feb. 16, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the fourth-quarter and full-year 2016 and provided detailed financial guidance for full-year 2017. Executive Summary "Net sales at constant curre
Read more →WSTWest Announces Fourth-Quarter and Full-Year 2016 Results and
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 West Announces Fourth-Quarter and Full-Year 2016 Results and Announces Quarterly Dividend - Conference Call Scheduled for 9 a.m. EST Today - Exton, PA, February 16, 2017 - West Pharmaceutical Se
Read more →WSTWest to Host Fourth-Quarter and Full-Year 2016 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Feb. 2, 2017 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release fourth-quarter and full-year 2016 financial results before the market opens
Read more →WSTWest Introduces LyoSeal® Instant Sealing Solution and NovaGuard® SA Pro Safety System at Pharmapack Europe Booth #H26 -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
EXTON, Pa. , Feb. 1, 2017 /PRNewswire/ -- Booth #H26 -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today introduced two new offerings at Pharmapack Europe 2017 . The LyoSeal® cap, an all-plastic, in
Read more →WSTWest to Present at J.P. Morgan Healthcare Conference West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of the Company's business at the 35th...
EXTON, Pa. , Dec. 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will be presenting an overview of the Company's business at the 35 th Annual J.P. Morgan Healthcare Conference, San Francisco, CA , at 3:30 p.m. PT on Wednes
Read more →WSTWest Pharmaceutical Services' Karen Flynn Receives Silver Stevie® Award in 2016 Stevie Awards for Women in Business West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today...
EXTON, Pa. , Dec. 20, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration and delivery, today announced that Senior Vice President and Chief Commercial Officer Karen Flynn has been named
Read more →WSTWest Receives Global Industry Recognitions for Innovative Contributions to Pharmaceutical Packaging and Drug Delivery West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and delivery, today...
EXTON, Pa. , Dec. 15, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration and delivery, today announced it has received multiple honors for innovation in the pharmaceutical industry inclu
Read more →WSTInvestor and Media Contact: West Quintin Lai, Investor Relations +1-610-594-3318 Quintin.Lai@westpharma.com West Announces Quarterly Dividend and Share Repurchase Program EXTON, PA
Investor and Media Contact: West Quintin Lai, Investor Relations +1-610-594-3318 Quintin.Lai@westpharma.com West Announces Quarterly Dividend and Share Repurchase Program EXTON, PA, December 14, 2016 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Com
Read more →WSTWest Announces Quarterly Dividend and Share Repurchase Program West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2017 dividend of $0....
EXTON, Pa. , Dec. 14, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors has approved a first-quarter 2017 dividend of $0.13 per share. The dividend will be paid on February 1, 2017 , to shareholders of recor
Read more →WSTWest Announces Expanded Contract Manufacturing Capabilities in Ireland West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
DUBLIN , Nov. 29, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced the completion of a 60,000 square foot expansion at its contract manufacturing facility near Mulhudd
Read more →WSTWest Announces Third Quarter 2016 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter 2016, updated financial guidance for the...
EXTON, Pa. , Oct. 27, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the third quarter 2016, updated financial guidance for the full-year 2016, introduced sales growth outlook for full-year 2017 and reaffirmed long-t
Read more →WSTWest Announces Third Quarter 2016 Results
Investor Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 West Announces Third Quarter 2016 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA October 27, 2016 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financ
Read more →WSTWest to Showcase Expertise in Injectable Drug Containment and Delivery at PDA Universe of Pre-filled Syringes & Injection Devices (Booth #504) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration and...
HUNTINGTON BEACH, Calif. , Oct. 17, 2016 /PRNewswire/ -- (Booth #504) -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration and delivery, today announced that it will participate in several educational sessi
Read more →WSTWest to Host Third Quarter 2016 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , Oct. 13, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release third quarter 2016 financial results before the market opens on Thursday, O
Read more →WSTWest Appoints David A.
Media Contact: Emily Denney, Global Communications +1-610-594-3035 Emily.Denney@westpharma.com West Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain Exton, PA -- September 26, 2016 -- West Pharmaceutical Services, Inc. (NYSE: WST), a glob
Read more →WSTWest Appoints David A. Montecalvo Senior Vice President, Global Operations and Supply Chain West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has...
EXTON, Pa. , Sept. 26, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it has appointed David A. Montecalvo to serve as Senior Vice President, Global Operations and S
Read more →WSTWest Elects New Director and Announces Increase to Quarterly Dividend
Investor and Media Contact: Quintin Lai, Investor Relations +1-610-594-3318 Quintin.Lai@westpharma.com West Elects New Director and Announces Increase to Quarterly Dividend EXTON, PA, September 12, 2016 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that th
Read more →WSTWest Elects New Director and Announces Increase to Quarterly Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors elected Paolo Pucci to fill the vacancy...
EXTON, Pa. , Sept. 12, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors elected Paolo Pucci to fill the vacancy following the retirement of Anthony Welters . Mr. Pucci, 54, is Chief Executive Officer of Ar
Read more →WSTWest to Present at Three Healthcare Conferences in September West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at three investor...
EXTON, Pa. , Sept. 2, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will be presenting an overview of West's business at three investor conferences in September. Management will present at the Baird 2016 Global Healthcare Co
Read more →WSTWest Announces Second Quarter 2016 Results
Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 West Announces Second Quarter 2016 Results - Conference Call Scheduled for 9 a.m. EDT Today - Exton, PA July 28, 2016 - West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results
Read more →WSTWest Announces Second Quarter 2016 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter 2016 and updated financial guidance for...
EXTON, Pa. , July 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the second quarter 2016 and updated financial guidance for the full-year 2016. Second Quarter 2016 Highlights "Adjusted diluted EPS" and "net sal
Read more →WSTWest to Host Second Quarter 2016 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , July 14, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release second quarter 2016 financial results before the market opens on Thursday,
Read more →WSTWest's SmartDose® Drug Delivery Technology Platform Selected by Amgen for Pushtronex™ System West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the...
EXTON, Pa. , July 11, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that the U.S. Food and Drug Administration (FDA) has approved the first combination product that
Read more →WSTWest Announces Quarterly Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a third-quarter 2016 dividend of $0....
EXTON, Pa. , July 5, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors has approved a third-quarter 2016 dividend of $0.12 per share. The dividend will be paid on August 3, 2016 , to shareholders of record a
Read more →WSTWest Introduces 1-3mL NovaPure® Plunger for Higher Volume Injections West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
EXTON, Pa. , June 7, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced the availability of the 1-3mL NovaPure® plunger—an innovative, high-quality component for pre-fil
Read more →WSTWest to Present at Investor Conference in June West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will present an overview of West's business at the Jefferies...
EXTON, Pa. , June 1, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will present an overview of West's business at the Jefferies Healthcare Conference in New York, NY , on Wednesday, June 8, 2016 at 11:30 a.m. EDT . A live au
Read more →WSTWest to Present at Two Investor Conferences in May West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will be presenting an overview of West's business at two investor...
EXTON, Pa. , May 4, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will be presenting an overview of West's business at two investor conferences in May. Management will present at the Bank of America Merrill Lynch 2016 Health
Read more →WSTWest Announces First Quarter 2016 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter 2016 and updated financial guidance for...
EXTON, Pa. , April 28, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the first quarter 2016 and updated financial guidance for the full-year 2016. First Quarter 2016 Highlights "Adjusted diluted EPS" and "net sale
Read more →WSTWest Announces First Quarter 2016 Results
Contact: Quintin Lai Vice President, Investor Relations (610) 594-3318 West Announces First Quarter 2016 Results Reports Quarterly Sales of $362 Million, Constant-Currency Sales Growth of 10.5% and Adjusted Diluted EPS of $0.53. Raises Lower-end of Full-year 2016 Sales and
Read more →WSTWest Makes Investment in NanoPass Technologies West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a...
EXTON, Pa. , April 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced a strategic investment in NanoPass Technologies Ltd. This investment will provide West with acc
Read more →WSTWest to Host First Quarter 2016 Conference Call West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , April 14, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it will release first quarter 2016 financial results before the market opens on Thursday,
Read more →WSTWest Announces Quarterly Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a second-quarter 2016 dividend of...
EXTON, Pa. , March 4, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the Company's Board of Directors has approved a second-quarter 2016 dividend of $0.12 per share. The dividend will be paid on May 4, 2016 , to shareholders of record as
Read more →WSTWest Pharmaceutical Services, Inc. (in millions, except per-share data) Presented "as if" 2016 reportable segment realignments were effective in 2015, in order to facilitate comparable analyses of 2016 reportable segment
West Pharmaceutical Services, Inc. (in millions, except per-share data) Presented "as if" 2016 reportable segment realignments were effective in 2015, in order to facilitate comparable analyses of 2016 reportable segment results to prior-year periods (UNAUDITED) 2015 Consolidate
Read more →WSTWest Appoints Eric Resnick to Chief Technology Officer West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced Eric...
EXTON, Pa. , March 1, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced Eric Resnick has been appointed to serve as Vice President and Chief Technology Officer, succeed
Read more →WSTWest to Host Analyst and Investor Day West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the...
EXTON, Pa. , Feb. 25, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that the Company will host an Analyst and Investor Day on Thursday, March 10, 2016 , from 8:30 a
Read more →WSTWest Announces Fourth Quarter and Full-Year 2015 Results
Contact: Quintin Lai Vice President, Corporate Development, Strategy & Investor Relations (610) 594-3318 West Announces Fourth Quarter and Full-Year 2015 Results Reports Quarterly Sales of $359.7 Million and Adjusted Diluted EPS of $0.47. Annual Sales of $1.4 Billion Generat
Read more →WSTWest's Daikyo Crystal Zenith® Cyclic Olefin Polymer Selected by Amgen West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that...
EXTON, Pa. , Feb. 12, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that global biotechnology leader Amgen Inc. has utilized West's Daikyo Crystal Zenith® (CZ) vial
Read more →WSTWest and Noble Collaborate to Improve Patient Education and Training for Self-Injection Systems West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug containment and delivery, today announced ...
EXTON, Pa. , Jan. 20, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug containment and delivery, today announced that the company is collaborating with Noble ®, a leader in patient-centric onboarding
Read more →WSTWest Announces New Organizational Structure
West Announces New Organizational Structure Exton, PA - Jan. 12, 2016 - West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a change to its organization and reporting structure that will supp
Read more →WSTWest Announces New Organizational Structure West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced a change...
EXTON, Pa. , Jan. 12, 2016 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced a change to its organization and reporting structure that will support the Company in its next p
Read more →WSTWest Announces Quarterly Dividend and Share Repurchase Program
West Announces Quarterly Dividend and Share Repurchase Program Exton, PA December 17, 2015 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 per share. The dividend will be
Read more →WSTWest Appoints George L.
West Appoints George L. Miller Senior Vice President, General Counsel and Corporate Secretary Exton, PA - November 19, 2015 - West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has appoin
Read more →WSTWest Appoints George L. Miller Senior Vice President, General Counsel and Corporate Secretary West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has...
EXTON, Pa. , Nov. 19, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it has appointed George L. Miller to serve as Senior Vice President, General Counsel and Corpora
Read more →WSTWest to Showcase Self-injection Systems and Prefillable Syringe Component Expertise at the PDA Universe of Pre-filled Syringes and Injection Devices (Booth #45-46) – West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today...
VIENNA , Nov. 2, 2015 /PRNewswire/ -- (Booth #45-46) – West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it will participate in several educational sessions and showcase innovative West pro
Read more →WSTWest Announces Third Quarter 2015 Results
Contacts: West Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506 West Announces Third Quarter 2015 Results Reports Sales of $344.5 million and Adjusted Diluted EPS of $0.44. Raises Fu
Read more →WSTWest Launches New Ready-to-Use/Validated Components at CPhI/InnoPack 2015 (Booth #4G30) -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative systems and component solutions for injectable drug...
MADRID , Oct. 13, 2015 /PRNewswire/ -- (Booth #4G30) -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative systems and component solutions for injectable drug administration, today launched Daikyo RUV® (ready-to-use/validated) components at CPhI Worldw
Read more →WSTWest Appoints Annette Favorite Senior Vice President and Chief Human Resources Officer West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced it has...
EXTON, Pa. , Sept. 30, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced it has appointed Annette Favorite to serve as Senior Vice President and Chief Human Resources O
Read more →WSTWest Pharmaceutical Services, Inc. and HealthPrize Technologies Announce Self-Reporting and Barcoding Capabilities for Self-Injection Technology West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC, today announced the completion of the first two phases of their...
EXTON, Pa. , Sept. 17, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) and HealthPrize Technologies, LLC , today announced the completion of the first two phases of their four-phase strategic collaboration. The companies are working to integrate HealthPrize's
Read more →WSTGeneral Media Inquiries: Investors and Financial Media: Emily Denney Senior Director, Communications (610) 594-3035 Michael A. Anderson Vice President and Treasurer (610) 594-3345 John Woolford Westwicke Partne
Contacts: General Media Inquiries: Investors and Financial Media: Emily Denney Senior Director, Communications (610) 594-3035 Michael A. Anderson Vice President and Treasurer (610) 594-3345 John Woolford Westwicke Partners (443) 213-0506 West to Purchase Group Annuity Contract f
Read more →WSTWest Announces Second Quarter 2015 Results
Contacts: West Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506 West Announces Second Quarter 2015 Results Delivers Sales of $359.7 million and Adjusted Diluted EPS of $0.47. Raises L
Read more →WSTWest Expands Manufacturing Capacity at Scottsdale Facility to Support Customer Demand for SmartDose® Electronic Wearable Injector West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that it...
EXTON, Pa. , July 20, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that it has expanded capabilities at its Scottsdale, Ariz. facility to meet increased customer d
Read more →WSTWest Celebrates Groundbreaking of Waterford, Ireland Manufacturing Facility West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative packaging components and drug delivery systems, hosted a groundbreaking ...
WATERFORD, Ireland , June 16, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative packaging components and drug delivery systems, hosted a groundbreaking ceremony in Waterford, Ireland today to mark the start of construction for the
Read more →WSTWest Bolsters R&D Strategy with Global Site Expansions & Upgrades West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative packaging components and drug delivery systems, today announced a...
EXTON, Pa. , May 12, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative packaging components and drug delivery systems, today announced a multi-year investment as part of the Company's evolving research and development strategy. To
Read more →WSTWest Announces First Quarter 2015 Results
Contacts: West Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506 West Announces First Quarter 2015 Results - Conference Call Scheduled for 9 a.m. Today - Exton, PA April 30, 2015 - We
Read more →WSTEric Green Appointed Chief Executive Officer of West Pharmaceutical Services Exton, PA
Eric Green Appointed Chief Executive Officer of West Pharmaceutical Services Exton, PA - April 15, 2015 - West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that Eric M. Green has been appoi
Read more →WSTWest Announces Fourth Quarter and Full Year 2014 Results
Contacts: West Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506 West Announces Fourth Quarter and Full Year 2014 Results - Conference Call Scheduled for 9 a.m. Today - Exton, PA Febr
Read more →WSTWest Launches High-Quality Flip-Off® PlusRU Seals West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced the...
EXTON, Pa. , Feb. 11, 2015 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced the availability of a new sterile drug vial seal, the Flip-Off® Plus RU seal. Part of West's Fli
Read more →WSTWest Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506 West Provides Required Notice of Automatic Conversion of Deben
West Provides Required Notice of Automatic Conversion of Debentures Exton, PA December 1, 2014 - West Pharmaceutical Services, Inc. (NYSE:WST) today announced the automatic conversion of the 4% convertible junior subordinated debentures due March 15, 2047 ("Debentures") that rem
Read more →WSTWest Receives 510(k) Clearance for NovaGuard™ SA Safety System West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that the...
EXTON, Pa. , Nov. 11, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, today announced that the NovaGuard SA (Staked-needle Automatic) safety system has received 510(k) clearance from
Read more →WSTWest Announces Third Quarter 2014 Results
Contacts: West Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506 West Announces Third Quarter 2014 Results - Conference Call Scheduled for 9 a.m. Today - Exton, PA October 30, 2014 -
Read more →WSTWest's Vial2Bag DC Device Receives U.S. FDA 510(k) Clearance and CE Mark West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has received 510(k)...
EXTON, Pa. , Oct. 21, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, has received 510(k) clearance of the Vial2Bag® DC device from the United States Food and Drug Administration, an
Read more →WSTWest Pharmaceutical Services Announces CEO Retirement and Succession Plan West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative drug packaging and administration systems, said today that Donald E....
EXTON, Pa. , Oct. 15, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative drug packaging and administration systems, said today that Donald E. Morel, Jr. , Ph.D., Chairman of the Board and Chief Executive Officer, has announced his
Read more →WSTWest Pharmaceutical Services Announces CEO Retirement and Succession Plan
West Contacts: Investors: Media: Michael A. Anderson Emily Denney Vice President and Treasurer Global Communications (610) 594-3345 (610) 594-3035 West Pharmaceutical Services Announces CEO Retirement and Succession Plan Chairman and CEO Donald E. Morel, Jr. to Retire at 2015
Read more →WSTWest Names New President of Pharmaceutical Packaging Systems West Pharmaceutical Services, Inc. (NYSE: WST) has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business....
EXTON, Pa. , Oct. 7, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Pharmaceutical Packaging Systems is a global business unit within West, and is the company's l
Read more →WSTWest Names New President of Pharmaceutical Packaging Systems
West Names New President of Pharmaceutical Packaging Systems Exton, Pennsylvania - October 7, 2014 - West Pharmaceutical Services, Inc. (NYSE: WST) has appointed Karen Flynn President of the company's Pharmaceutical Packaging Systems business. Pharmaceutical Packaging Systems is
Read more →WSTWest Pharmaceutical Services and HealthPrize Technologies Join Forces on Connected Health West Pharmaceutical Services, Inc. (NYSE: WST) and HealthPrize Technologies, LLC today announced a strategic collaboration to integrate HealthPrize's ...
EXTON, Pa. , Oct. 6, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) and HealthPrize Technologies, LLC today announced a strategic collaboration to integrate HealthPrize's Software-as-a-Service (SaaS) medication adherence and patient engagement platform with
Read more →WSTWest Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, announced today it plans...
WATERFORD, Ireland , Oct. 2, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, announced today it plans to expand its global manufacturing operations to include a new site in Waterford
Read more →WSTWest Announces Plans for a New Pharmaceutical Component
Contacts: West Inquiries: IDA Inquiries: Emily Denney Kevin Sammon West Global Communications IDA Ireland + 1-610-594-3035 + 353876188564 Emily.Denney@westpharma.com kevin.sammon@ida.ie West Announces Plans for a New Pharmaceutical Component Manufacturing Plant in Ireland Exp
Read more →WSTWest Announces Second Quarter 2014 Results
Contacts: West Michael A. Anderson Vice President and Treasurer (610) 594-3345 Investors and Financial Media: Westwicke Partners John Woolford (443) 213-0506 West Announces Second Quarter 2014 Results - Conference Call Scheduled for 9 a.m. Today - Exton, PA July 31, 2014 - We
Read more →WSTWest To Host Second Quarter 2014 Conference Call West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release second quarter 2014 financial results before the market opens on...
EXTON, Pa. , July 24, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) announced today that it will release second quarter 2014 financial results before the market opens on Thursday, July 31, 2014 and will follow with a conference call to discuss the results a
Read more →WSTWest Announces 10% Increase in Quarterly Dividend
West Announces 10% Increase in Quarterly Dividend Exton, PA July 16, 2014 -- West Pharmaceutical Services, Inc. (NYSE:WST) today announced that the Company's Board of Directors has approved a fourth-quarter 2014 dividend of $0.11 per share, a 10% increase over the $0.10 per shar
Read more →WSTWest Dedicates Pharmaceutical Manufacturing Plant in India West Pharmaceutical Services, Inc. (NYSE: WST) has dedicated its manufacturing plant in the Sri City Special Economic Zone (SEZ), where the company...
CHENNAI, India , July 16, 2014 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) has dedicated its manufacturing plant in the Sri City Special Economic Zone (SEZ), where the company will expand its growing primary packaging for injectable medicines business. "West
Read more →WSTWest Completes Preliminary Study Evaluating the SmartDose Electronic Patch Injector Technology Platform, Which Incorporates a Daikyo Crystal Zenith Cartridge West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has completed a...
EXTON, Pa. , Nov. 7, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, has completed a preliminary study of its SmartDose® technology platform, which incorporates a Daikyo Crystal Zeni
Read more →WSTWest to Co-present Research Findings on Understanding the Patient Journey through the Phases of a Chronic Disease West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, has completed primary...
EXTON, Pa. , Nov. 1, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative solutions for injectable drug administration, has completed primary user research with its partner, Insight Product Development, aimed at understanding the nee
Read more →WSTWest Expands NovaGuard™ Platform of Products for Safe and Effective Injectable Drug Delivery West Pharmaceutical Services, Inc. (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery,...
EXTON, Pa. , July 2, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a leading global developer and manufacturer of components and systems for injectable drug delivery, today announced the expansion of the NovaGuard portfolio of needle safety products. The N
Read more →WSTWest to Celebrate 90 Years of Healthcare Innovation at the NYSE Today, representatives from West Pharmaceutical Services, Inc. (NYSE: WST), will celebrate the company's 90th anniversary by ringing the closing bell ...
EXTON, Pa. , June 20, 2013 /PRNewswire/ -- Today, representatives from West Pharmaceutical Services, Inc. (NYSE: WST ), will celebrate the company's 90 th anniversary by ringing the closing bell at the New York Stock Exchange. The closing ceremony at the stock exchange commemorat
Read more →WSTWest Celebrates 90 Years of Healthcare Innovation Today, West Pharmaceutical Services, Inc. (NYSE: WST), a world leader in pharmaceutical and biotech drug packaging and delivery, celebrated the...
EXTON, Pa. , April 15, 2013 /PRNewswire/ -- Today, West Pharmaceutical Services, Inc. (NYSE: WST ), a world leader in pharmaceutical and biotech drug packaging and delivery, celebrated the company's 90 th anniversary. This landmark occasion commemorates West's long history of wor
Read more →WSTWest Announces the Commercial Introduction of a Novel Intradermal Adapter for Disposable Syringes West Pharmaceutical Services, Inc. (NYSE: WST), a leading global developer and manufacturer of components and systems for injectable drug delivery,...
EXTON, Pa. , Feb. 27, 2013 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a leading global developer and manufacturer of components and systems for injectable drug delivery, announces the commercial introduction of its ID Adapter . West acquired a license to the
Read more →WSTWest Pharmaceutical Services to Share Insights and Showcase Solutions for Drug Delivery, Safety and Efficacy at PDA Conference and AAPS Annual Meeting West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative system and component solutions for injectable drug administration,...
LIONVILLE, Pa. , Oct. 11, 2012 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), a global leader in innovative system and component solutions for injectable drug administration , today announced that company representatives will be speaking in several educational s
Read more →WSTWest Increases Quarterly Dividend to $0.18 West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has approved an increase of one cent per share in the...
LIONVILLE, Pa. , Oct. 7, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that its Board of Directors has approved an increase of one cent per share in the Company's quarterly cash dividend, to $0.18 per share, beginning in the fourth quarter o
Read more →WSTWest to Present at Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will participate in two upcoming investor conferences. Management will ...
LIONVILLE, Pa. , Sept. 7, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will participate in two upcoming investor conferences. Management will attend the 9th Annual CL King & Associates Best Ideas Conference in New York, NY
Read more →WSTWest Announces Second Quarter 2011 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the second quarter of 2011. Summary comparative results were ...
LIONVILLE, Pa. , July 28, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the second quarter of 2011. Summary comparative results were as follows: Second-quarter 2011 net sales grew 9.3% from the same period last yea
Read more →WSTWest to Host 2011 Second Quarter Conference Call West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release 2011 second quarter financial results before the market opens on...
LIONVILLE, Pa. , July 21, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) announced today that it will release 2011 second quarter financial results before the market opens on Thursday, July 28, 2011 and will follow with a conference call to discuss the resul
Read more →WSTWest to Present at Jefferies Conference West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the Jefferies 2011 Global Healthcare Conference in New...
LIONVILLE, Pa. , May 31, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will attend the Jefferies 2011 Global Healthcare Conference in New York, NY . Management will present an overview of West's business and outlook on Monday
Read more →WSTWest Announces Third Quarter 2011 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has approved payment of the third-quarter 2011 cash...
LIONVILLE, Pa. , May 6, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that its Board of Directors has approved payment of the third-quarter 2011 cash dividend of $0.17 per share. The dividend will be paid on August 3, 2011 to shareholders of
Read more →WSTWest Announces First Quarter 2011 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the first quarter of 2011. Summary comparative results were...
LIONVILLE, Pa. , April 28, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the first quarter of 2011. Summary comparative results were as follows: (1) See "Restructuring and Other Items" section of the release and "S
Read more →WSTWest to Host 2011 First Quarter Conference Call West Pharmaceutical Services, Inc. (NYSE:WST) announced today that it will release 2011 first quarter financial results before the market opens on...
LIONVILLE, Pa. , April 21, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) announced today that it will release 2011 first quarter financial results before the market opens on Thursday, April 28, 2011 and will follow with a conference call to discuss the resu
Read more →WSTWest to Present at Barclays Capital Conference West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the Barclays Capital 2011 Global Healthcare Conference in...
LIONVILLE, Pa. , March 9, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will attend the Barclays Capital 2011 Global Healthcare Conference in Miami, FL. Management will present an overview of West's business and outlook on We
Read more →WSTWest Appoints Two Directors and Announces Second Quarter 2011 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors increased the size of the Board to twelve and appointed...
LIONVILLE, Pa. , Feb. 24, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that its Board of Directors increased the size of the Board to twelve and appointed two new directors, Mr. Mark A. Buthman and Mr. Douglas A. Michels . Each of their ter
Read more →WSTWest Announces Fourth Quarter 2010 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its fourth-quarter and full-year financial results for 2010. Summary comparative...
LIONVILLE, Pa. , Feb. 17, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its fourth-quarter and full-year financial results for 2010. Summary comparative results for the fourth quarter were as follows: Fourth-quarter 2010 sales were $16.6 mi
Read more →WSTWest to Host 2010 Fourth Quarter Conference Call West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release 2010 fourth quarter financial results before the market opens on...
LIONVILLE, Pa. , Feb. 10, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) announced today that it will release 2010 fourth quarter financial results before the market opens on Thursday, February 17, 2011 and will follow with a conference call to discuss the r
Read more →WSTWest to Present at UBS Investor Conference West Pharmaceutical Services, Inc. (NYSE: WST) today announced that management will attend the UBS 21st Annual Global Healthcare Services Conference...
LIONVILLE, Pa. , Feb. 1, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that management will attend the UBS 21st Annual Global Healthcare Services Conference in New York, NY . Management will present an overview of West's business and outlook
Read more →WSTWest Names New President of Pharmaceutical Packaging Systems West Pharmaceutical Services, Inc. (NYSE: WST) has appointed Jeffrey C. Hunt President of the Company's Pharmaceutical Packaging Systems business,...
LIONVILLE, Pa. , Jan. 5, 2011 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) has appointed Jeffrey C. Hunt President of the Company's Pharmaceutical Packaging Systems business, previously headed by Steven A. Ellers , the Company's President and Chief Operating Of
Read more →WSTWest Announces First Quarter 2011 Dividend West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has approved payment of the first-quarter 2011 cash...
LIONVILLE, Pa. , Dec. 16, 2010 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that its Board of Directors has approved payment of the first-quarter 2011 cash dividend of $0.17 per share. The dividend will be paid on February 2, 2011 to s
Read more →WSTWest Announces Plan to Consolidate Certain Operations West Pharmaceutical Services, Inc. (NYSE: WST), today announced its intention to consolidate selected operations in order to improve operating...
LIONVILLE, Pa. , Dec. 7, 2010 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST ), today announced its intention to consolidate selected operations in order to improve operating efficiencies. The Company expects to close its Montgomery, Pennsylvania , USA ma
Read more →WSTWest Announces Third Quarter 2010 Results West Pharmaceutical Services, Inc. (NYSE: WST) today announced its financial results for the third quarter of 2010. Summary comparative results were...
LIONVILLE, Pa. , Nov. 2, 2010 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced its financial results for the third quarter of 2010. Summary comparative results were as follows: Sales increased 4.8% in the third quarter compared to the 200
Read more →WSTWest to Host 2010 Third Quarter Conference Call West Pharmaceutical Services, Inc. (NYSE: WST) announced today that it will release 2010 third quarter financial results before the market opens on...
LIONVILLE, Pa. , Oct. 26 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) announced today that it will release 2010 third quarter financial results before the market opens on Tuesday, November 2, 2010 and will follow with a conference call to discuss the
Read more →WSTWest Increases Quarterly Dividend to $0.17 West Pharmaceutical Services, Inc. (NYSE: WST) today announced that its Board of Directors has approved an increase of one cent per share in the...
LIONVILLE, Pa. , Oct. 4 /PRNewswire-FirstCall/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that its Board of Directors has approved an increase of one cent per share in the Company's quarterly cash dividend, to $0.17 per share, beginning in the fourth quart
Read more →WSTWest to Participate at Upcoming Investor Conferences West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the company will participate in two upcoming investor conferences. Donald E....
LIONVILLE, Pa. , Sept. 9 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST ) today announced that the company will participate in two upcoming investor conferences. Donald E. Morel, Jr. , Ph.D., Chairman and Chief Executive Officer, and William Federici , Chief Finan
Read more →Competitive Position
How WST ranks across every disease it competes inCompetitive Position is a premium feature
See how WST ranks against every competitor across each disease it develops in: phase, best drug, trials and likelihood of approval.
Start free trial